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ABSTRACT 
In recent years particular attention has been focused on the properties of melanin pigments 
with regard to their association with some pathological conditions and to their controversial 
role in the response of skin to solar radiation.  
This is especially true in the case of pheomelanins, typical of red hair phenotype, with red hair 
pale skin, blue-green eyes and freckles. People exhibiting this phenotype have poor tanning 
capacity, exhibit a UV-susceptibility trait with high tendency to sunburn and an increased risk 
for skin tumors and melanoma.
 
On the other hand, eumelanins are commonly believed to be the most important 
photoprotective factor,  even if evidence accumulating over the last decades highlight a much 
more controversial role of eumelanins in human pigmentation.
 
On these bases, the research 
work carried out during the PhD course and reported in this thesis was directed at 
investigating  the light-independent effects of purified human hair melanins on keratinocyte 
cell cultures with particular attention to their pro-oxidant properties and at defining the origin 
of the broadband absorption spectrum of eumelanin, which underpins their protective 
shielding effect. 
Based on the consideration that, besides eumelanin pigments, the entire melanogenic pathway 
is relevant to melanocyte function, the effect of carboxyl group substituent of indole 
precursors on eumelanin properties was evaluated and a suitable derivative of 5,6-
dihydroxyindole-2-carboxylic acid (DHICA) was prepared to assess the photoprotective 
properties for potential application in sunscreen formulations. 
Local excess of pigmentation is one of the most common pigmentary disorder
5
 whose 
aesthetically impact has urged the search for efficient strategies for control of skin 
pigmentation. As a preliminary approach toward the implementation of a novel skin 
depigmenting agent a conjugate of caffeic acid with dihydrolipoic acid was prepared and 
tested for its ability to inhibit mushroom tyrosinase activity. 
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CHAPTER 1 
1.1 Melanin pigmentation 
Melanin pigmentation is believed to be one of the main determinants of sensitivity to 
ultraviolet (UV) light and susceptibility to sun damage, including photoaging, skin cancer and 
melanoma and it is important for skin homeostasis.
1
  
Together with increasing epidermal thickness, DNA repair mechanisms, apoptosis and 
antioxidant enzymes, skin pigmentation is one of the endogenous mechanisms developed to 
protect skin from environmental influences. 
Two main varieties of melanin pigments, the black-to-brown indolic eumelanin and the 
reddish sulfur-containing pheomelanin are known. 
Eumelanins are commonly believed to be the most important photoprotective factor, 
providing protection against sunlight-induced burns, DNA damage and skin cancer, thanks to 
the broad absorption spectrum and the free radical scavenging properties.
2–5 
Epidemiological 
studies showed an inverse correlation between skin pigmentation and incidence of light-
induced skin cancers: people with darker skin (richest in eumelanin) are less prone to skin 
cancer compared to those with fair skin.
3
  
Yet, evidence accumulating over the last decades has highlighted a much more controversial 
role of melanins in human pigmentation, suggesting a more complex interplay between 
pigmentation and photoprotection.
6
 For example, melanin is known to protect DNA from 
damage induced by UV radiation, but it is also known to act as a photosensitizer that 
generates reactive oxygen species (ROS) upon UV irradiation, inducing oxidative base lesions 
and DNA strand breaks in vitro or in cultured cells.
7
 
Particular attention has traditionally been focused on the red hair phenotype typically found in 
individuals of Celtic origin, with red hair pale skin, blue-green eyes and freckles. People that 
exhibit this phenotype, have a higher ratio of yellow pheomelanin to brown eumelanin
8
, have 
poor tanning capacity, exhibit an UV-susceptibility trait, a high tendency to sunburn and an 
increased risk for skin tumors and melanoma.
9–12
 Pheomelanins are photolable under 
physiologically relevant conditions
13,14
 and can generate ROS following UVR exposure, 
possibly causing mutation in skin cells and damaging important biological targets.
15
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1.2 Melanin biosynthesis  
Under physiological conditions, melanin synthesis in melanocytes is restricted to 
melanosomes, membrane-bound organelles whose structures differs according with the type 
of melanin produced: eumelanosomes are elliptical and are characterized by the content of 
fibrillary matrix, pheomelanosomes are rounded shaped and contains a vesicular matrix. 
Melanogenesis is under complex regulatory control by multiple agents interacting via 
pathways activated by receptor-dependent and -independent mechanisms.
2
 
 
It has long been known that both eumelanins and pheomelanins originate from the tyrosinase-
catalyzed oxidation of L-tyrosine whose availability depends either on transport from 
extracellular space or on hydroxylation of L-phenylalanine to L-tyrosine, a nonobligatory 
step, operative in vivo. 
L-tyrosine is hydroxylated by tyrosinase to L-dihydroxyphenylalanine (L-DOPA) (Scheme 1); 
further steps of melanogenesis can occur spontaneously, at varying rates depending on pH, 
presence, and concentration of metal cations (particularly zinc and iron), reducing agents, 
thiols, and oxygen.
16
  
10 
 
 
Scheme 1.  Melanogenesis. 
The oxidation product of tyrosine, dopaquinone (common to both eu- and pheomelanogenic 
pathways), undergoes different fates depending on the presence/absence of cysteine.  
Dopaquinone is an orthoquinone which reacts extremely rapidly with thiol compounds but 
rather slowly with amines, so when concentration of sulfhydryl compounds is low, 
dopaquinone undergoes an intramolecular reaction of the amino group to give dopachrome 
via leukodopachrome, followed by a series of oxidation-reduction reactions with production 
of the intermediates 5,6-dihydroxyindole (DHI) and 5,6-dihydroxyindole-2carboxylic acid 
(DHICA), that undergo polymerization to form eumelanin. If in vitro the decarboxylation of 
11 
 
dopachrome is favored, in vivo the tyrosinase-related protein Dopachrome tautomerase (Dct, 
Tyrp 2) directs the fate of dopachrome toward tautomerization with non-decarboxylative 
formation of DHICA, a major circulating melanogen.
17
  
Also metal cations such as copper, zinc, and iron can affect the composition of the melanin 
polymer, being involved in the rearrangement of dopachrome to DHICA.
18
  
When sufficient levels of L-cysteine are present in melanosomes, it undergoes a non-
enzymatically conjugation with dopaquinone forming the isomers 5-S- and 2-S-cysteinyldopa 
(5SCD and 2SCD) in a ratio of 5:1.
19
 As a result, the intramolecular cyclization pathway of 
5,6-dihydroxyindole formation leading to eumelanin polymers is decreased or inhibited, and 
an alternate 1,4-benzothiazine route to pheomelanins becomes dominant. Pheomelanogenesis 
is also favored at acidic pH because the cyclization of dopaquinone proceeds much slower 
than the cysteinyldopa quinone cyclization.
9
 
Oxidation of cysteinyldopas, e.g. 5SCD followed by intramolecular cyclization would then 
lead to the generation of a transient o-quinoneimine which can either undergo redox exchange 
with the parent cysteinyldopa to give a dihydrobenzothiazine or isomerize with or without 
concomitant decarboxylation to give 2H-1,4-benzothiazine derivatives which undergo 
oxidative polymerization leading eventually to the pigment.
20,21
 
Metal can also affect the reactivity of intermediates of pheomelanogenesis.
22
 In the presence 
of zinc ions, the most abundant trace element present in skin and hair, CD-zinc complexes are 
formed the undergo oxidation at higher rates with respect to free CD and decarboxylation of 
the quinoneimine is substantially inhibited so that the 3-carboxy derivative is the main 
product which persists in the reaction medium for relatively long periods of time due to the 
stabilizing effect of the metal.
23,24
 
Just formed, the 2H-1,4-benzothiazine derivatives may follow diverse routes reflecting the 
presence or the absence of the carboxyl group on the 3-position, and the specific reaction 
conditions.  
Alkaline or hydrogen peroxide treatment of 1,4-benzothiazines leads to a stable 3-oxo 
derivative (path a, Scheme 2).
24
 
An intriguing oxidative dimerization process leading to the 2,2’bibenzothiazines (path b, 
Scheme 2) can be observed by spontaneous oxidation under mild condition.
20
  
 
12 
 
 
Scheme 2. Main reaction routes of benzothiazine intermediates of pheomelanogenesis under 
physiological relevant conditions. 
Further oxidative steps lead to unusual bibenzothiazine derivatives commonly referred to as 
the trichochromes. These latter comprise four main variants, two of which consist of 
symmetric bibenzothiazine derivative (trichochromes E and F) while the other two are mixed 
systems (trichochromes B and C).
25
 
By far one of the most typical chemically and biologically relevant characteristic of the 2H-
1,4-benzothiazines is their tendency to undergo ring contraction either spontaneously or 
following UV irradiation to give benzothiazole products BTCA and BT (path c, Scheme 2).
26
 
This process has been described as a major post-biosynthetic modification of pheomelanins 
and the levels of benzothiazole inside the pigment are taken as marker of aging of the pigment 
itself.
27
  
Benzothiazole-carboxylic acids from isomeric cysteinyldopas have been used as markers of 
high levels of hair pheomelanin and increased risk of skin cancer and melanoma.
28,29
 
Pathway d in Scheme 2 entails an outstanding sequence of spontaneous chemical processes, 
which is probably triggered by the coupling of two oxidized benzothiazine species.
30
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The main dimeric product (DHIQ), featuring dihydroisoquinoline and benzothiazole moieties, 
has been shown to provide the most important building blocks of natural pigments from red 
hair and chicken feathers.
31,32
 Current evidence indicates that most of red hair pheomelanin 
properties, including UV-visible chromophore and chemical degradation marker profile are 
matched fairly well by the unusual dimer generated as in path d.
31
 
Most of natural melanin are considered to be mixtures of eumelanin and pheomelanin so 
melanogenesis should be considered as “mixed melanogenesis”.8 The ratio of eumelanin to 
pheomelanin is determined by tyrosinase activity and the availability of tyrosine and cysteine 
in melanosomes.
33
 Kinetic data suggest that pheomelanin production comes first, followed by 
eumelanin deposition
33,34
 so this “casing model” envisages melanin granules consisting of a 
pheomelanin core covered by an eumelanin surface.
34,35
  
1.2 UV radiation, (photo)damage and skin role in (photo)protection 
The UV radiation spectrum can be subdivided into ultraviolet A (UVA), from 320 to 400 nm, 
ultraviolet B (UVB), from 280 to 320 nm and ultraviolet C (UVC) from 200 to 280 nm, but 
this short wavelength part of the spectrum does not reach the Earth’s surface because is 
absorbed by ozone layer and screened out by atmospheric oxygen.
1
  
 
Figure 1. Schematic representation of electromagnetic spectrum. 
Excessive UVR exposure is known to be responsible for a wide variety of different acute and 
chronic effects on the skin. Acute responses of human skin to UVR include photodamage, 
erythema, mutation, immunosuppression, synthesis of vitamin D and tanning. Chronic UVR 
effects include photoaging and photocarcinogenesis, which is considered to be induced by 
Visible InfraredUVAUVBUVC
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Epidermis
Dermis
Hypodermis
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mutation and immunosuppression.
36
 
UVA and UVB show different properties regarding their biological effects on skin and can act 
through multiple mechanisms. UVB radiation is more cytotoxic and mutagenic than UVA and 
can directly damage DNA but is filtered by windows glass, while UVA is able to penetrate in 
the skin reaching the dermis and it is mainly responsible for indirect DNA damage by ROS 
generation.
1
 
One of the most important photolesions induced by UVB, even at suberythemal doses, are 
cyclobutane pyrimidine dimers (CPD) that contain a cyclobutane ring arising from the 
reaction between the carbon-carbon double bond of two adjacent pyrimidine 
37
.This 
cycloaddition forces the bases close to each other, altering the DNA structure. The nucleotide 
excision repair (NER) mechanism can repair dimers but it is sometimes overwhelmed so 
unpaired dimers can accumulate and possibly lead to skin cancer.
38
  
CPDs are responsible for a wide range of acute effects (e.g. erythema and inflammatory 
response), transient effects (suppression of immune function) and chronic effects (DNA 
mutation and carcinogenesis).
38
 
CPDs lead to highly specific mutation, namely (cytosine-cytosine) CC → (tymine-tymine) TT 
double base substitutions and C→T substitutions at dipyrimidine sites that are known as UVR 
“fingerprint mutations” or “UV signature mutations”.39 C to T substitutions are typically 
found  in human melanomas.
40
  
UVA is able to damage DNA producing reactive singlet oxygen (
1
O2) that interacts with 
guanine (G) moieties, giving oxidized products such as 8-oxo-7,8-dihydroguanine. Moreover 
UVA can promote the formation of hydroxyl radicals that can induce less specific damages to 
DNA. 
UVA, even if weakly absorbed by DNA, can generate CPDs
41
 accounting for a higher 
induction of T=T CPDs than UVB
42–44
 but, while UVB induction of CPDs is associated with 
the production of (6-4) pyrimidone photoproducts (6-4PPs), in the case of UVA 6-4PPs are 
not generated.
41,45
  
Two different mechanisms seem to be involved in UV-induced melanoma via CPDs. Studies 
on murine skin showed that CPDs are induced in black and albino mice mainly by UVB 
radiation while UVA production of CPD is less efficient.
46
  
15 
 
A new mechanism involving melanin has been recently proposed by Premi and coworkers in 
2015,
47
 suggesting that CPDs are produced in the dark by chemiexcitation,
48,49
 i.e. the 
generation of electronically excited molecules by chemical reaction. This work has been the 
focus of a review article prepared during the PhD course.  
According with this study, superoxide (O2
•– 
) ions generated by NADPH  oxidase (NOX), and 
nitric oxide (NO
•
) generated by induced nitric oxide synthase react to give peroxynitrite 
(ONOO
-
),
50
 an oxidant that is able to generate dioxetanes that by thermolysis are cleaved to 
two carbonyls.  One of these carbonyls is in the high energy triplet state
51
 and can transfer 
energy to DNA  in a non-radiative manner bases generating dimers via cycloaddition.   
In this contest, melanin would act as molecular vector, acting as a triplet-state carrier. 
Synthetic eumelanin, DHICA and 5SCD can be oxidized by peroxynitrite and enter the 
nucleus
47
 where they transfer energy to DNA and generate CPDs even hours after UV 
exposure has ended (delayed or “dark” CPDs). In particular, a product of oxidation of DHICA 
likely obtained via a muconic-type C-C cleavage or a 1,2-dioxetane mediated C-C cleavage 
has been identified as a possible triplet-carrier carbonyl.
52
  
 
Figure 2. A proposed mechanism for the bright and the dark pathways of cyclobutane 
pyrimidine dimers (CPDs) production.  
Human skin has developed two main defense mechanisms against the damaging effects of 
UV: epidermal thickening and the stimulation of melanin synthesis that play a key role in 
photoprotection.
1
 Epidemiological data strongly support the photoprotective role of melanin 
as there exists an inverse correlation between skin pigmentation and the incidence of sun-
induced skin cancers.
53,54
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UV exposure induces skin pigmentation that follows different phases: 
 Immediate pigment darkening (IPD) shows a broad peak in UVA region, occurs 
within minutes of exposure and fades over some days. It is not due to melanin 
synthesis but to photooxidation of already formed melanin.
55
  
 Persistent pigment darkening (PPD) is mainly induced by UVA and results from 
oxidation of pre-formed melanin and fades over 3-5 days.
56,57
  
 Delayed tanning (DT) can be induced both by UVA and UVB, occurs 2 or 3 days 
after UV exposure and is completely different from IPD, displaying a different action 
spectrum.
58
 DT results from synthesis of new melanin and it is associated with an 
increase of tyrosinase activity.
59
. 
The protective effect of melanin is achieved by its capacity to serve as shielding filter that 
absorbs UV reducing its penetration through the skin, however melanin role is not merely 
that of a sunscreen.
60
  
For example, melanin is able to quench excited states of photosensitizers and singlet 
oxygen (
1
O2) and to act as scavenger of ROS, playing an important role in protection 
against oxidative damage.
60
 
Actually, synthetic melanin can react with both oxidizing and reducing radicals because 
the hydroquinone and quinone subunits allow it to act both as electron donor and 
acceptor. Melanin can also protect DNA from H2O2-induced DNA damage through its 
ability to bind Ca
2+
.
61
  
Even if it is generally accepted that melanin acts as a natural sunscreen and protective 
agent, the relationship between pigmentation and photoprotection seems to be by far 
more complex than generally assumed as melanin can also have toxic effects,
7
 especially 
after exposure to UVR.
62–64
 In vitro studies showed that after UVA irradiation, it 
generates ROS that can indirectly induce oxidative base lesions, damaging DNA.
65,66
 
The tyrosine-derived aromatic rings of the melanin chromophore are excited to the singlet 
state, decay to the triplet, and transfer an electron to oxygen to yield superoxide.
14
 Some 
evidence also indicates transfer of excitation from the chromophore to oxygen, giving 
singlet oxygen which can react with several targets. Reaction of superoxide with iron (III) 
ions and hydrogen peroxide (created by dismutation of superoxide) can lead to the OH
•
 
radical, which is capable of causing DNA strand breaks. Melanins subsequently scavenge 
these active chemical species, but their scavenging capacity can be overwhelmed. In 
17 
 
living skin exposed to UV, it is not known which of these opposing mechanisms 
predominates.
67
  
Pheomelanin, that is especially prone to photodegradation,
13,68
 amplifies these effects 
contributing to the damaging effects of UVR by generation of hydrogen peroxide and 
superoxide anions.
14,18
  
Melanin should then be regarded as a double-edge sword, being carcinogenic as well as 
protective against cancer, so further investigation on the its role in the UV immune and 
antioxidant responses and on the chemistry of eumelanin and pheomelanin precursors, 
would improve our understanding its contribute to the risk of carcinogenesis not only due 
to UV exposure but even in the dark.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
CHAPTER 2 
2.1 Pheomelanin pigments: (photo)toxicity and pro-oxidant properties 
Since the discovery in 1995 that people with red hair display mutations in the human 
melanocortin 1 receptor (MC1R), the genetic of pigmentation has been largely investigated.
3
  
Indeed, among the more than 120 genes involved in the regulation of pigmentation, only the 
melanocortin 1 receptor gene (mc1r) is known to account for variation in skin and hair 
pigmentation and in skin cancer incidence. The mc1r gene encodes a 317–amino acid G-
coupled receptor, MC1R.  
Human mc1r sequence variants are associated with red hair and fair skin in the Caucasian 
population.
69–71
 These variant alleles are extremely common, and in northern European 
populations < 50% of the mc1r genes encodes the ‘wild-type’ or consensus protein. Three 
alleles in particular, Arg151Cys, Arg160Trp and Asp294His together make up 22% of the 
mc1r genes and account for 60% of all cases of red hair. Thus, a single locus can contribute 
significantly to human pigmentary variation. 
The MC1R gene is regulated positively by -melanocyte-stimulating hormone (-MSH) and 
negatively by antagonists of MC1R, such as Agouti signal protein (ASIP) and beta-defensin 
3, competing with -MSH.72,73  
 In wild-type eumelanic subjects, MC1R activation induces eumelanin synthesis via 
tyrosinase activation. Among red haired individuals, homozygous for alleles of the mc1r gene 
can be found, that show varying degrees of diminished function. The main consequence is a 
decrease in the amount of eumelanin pigments with prevalence of the pheomelanin variant. 
At the biochemical level, this change is the result of the drop in tyrosinase activity favoring 
the concomitant intervention of cysteine in the pathway.  
MC1R is even implicated in controlling ROS-induced DNA damage, regulating the levels of 
two enzymes involved in DNA repair, namely 8-oxoguanine DNA glycosylase (OGG1) and 
apurinic apyrimidinic endonuclease.
74
 
In spite of the many advances carried out in the last years in the elucidation of the structure 
and biosynthesis of pheomelanin pigments, the relationship between the structural features 
and the role of the pigments in determining the skin cancer proneness of red hair phenotypes 
has not been fully elucidated. 
19 
 
Traditionally, the positive correlation between red hair and melanoma has been attributed to 
both the poor antioxidant and photoprotective properties of pheomelanins compared to the 
dark eumelanins, and the capacity of pheomelanin to act as photosensitizer inducing 
generation of ROS upon irradiation with UV light.
7,10,14,75,76
 
These effects have been extensively investigated either on cell cultures
10
 or in vitro by 
Electron Paramagnetic Resonance (EPR) oxymetry using synthetic pheomelanins prepared 
under different conditions showing an enhanced photoreactivity for the synthetic pigments 
obtained in the presence of zinc ions under which conditions the formation of benzotiazine-2-
carboxylic acid BTCA and DHIQ is favored.
75
 
Pheomelanin chromophore can be excited to the singlet state;
14
 decaying to the triplet it can 
transfer an electron to oxygen generating superoxide anion or singlet oxygen, both able to 
damage DNA. Moreover singlet oxygen can destruct the pigment itself.
77
 
Evidence has also been obtained that red hair pheomelanins undergo significant structural 
modifications on exposure to air and solar light during hair growth, being readily 
photodegraded under physiologically relevant conditions.
28
 All these data however have not 
so far been reconciled into a coherent picture correlating the structure features of the pigment 
with the photoreactivity. 
Two UV-dependent pathways for the induction of melanoma have been identified, which 
revealed an unexpected and significant role for melanin in melanomagenesis:
46
 while UVB is 
able to induce DNA damage in a direct manner, UVA requires the presence of melanin. 
Nonetheless, direct relationship between sun exposure and melanoma is still missing, and 
issues have been raised of why melanoma is not restricted to sun-exposed areas of the body, 
and UV radiation signature mutations are infrequently oncogenic drivers.
78
  
A further issue of great relevance to the mechanisms of toxicity associated to pheomelanic 
pigmentation has recently been disclosed by a series of papers that claimed identification of 
UV-independent pathway for the induction of melanoma.
6,78–80
  
Multiple experiments show that an activating mutation of BRAF into red hair mice 
melanocytes resulted in a high incidence of invasive melanomas in the absence of UV-light.
79
 
Introduction of an albino allele that inhibits pigment production showed that the absence of 
pheomelanin is protective against melanoma development. 
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In addition, pheomelanic mice’s skin contained higher levels of oxidative DNA and lipid 
damage than albino-Mc1re/e mice.
79
 These data suggested that the pheomelanin pathway 
produces UV-independent carcinogenic contributions to melanomagenesis, probably by a 
mechanism of oxidative damage.  
Oxidative damage seems to play a key role in melanoma formation, however the actual 
mechanisms implicated in pheomelanin-induced UV-independent oxidative stress, DNA 
damage and melanomagenesis have remained unclear.  
Pheomelanin synthesis is associated with increased oxidative stress in the skin. Two possible 
not mutually exclusive pathways by which the pheomelanin pathway could mediate oxidative 
stress and melanomagenesis were postulated:
80
 
 The pheomelanin biosynthetic pathway envisages the incorporation of cysteine that is 
mainly stored in glutathione, the most important cellular antioxidant. So it would be 
the synthesis, rather than the presence of pheomelanin to make the cell more 
vulnerable to elevated ROS levels oxidative stress. 
 Although pheomelanin is not located in the nucleus, it might cause damage by 
promoting the formation of ROS, which could overwhelm cellular antioxidant 
reserves and cause oxidative damage to biomolecules.
81
 It is known that pheomelanin 
can generate ROS after UVA exposure, but the study by Mitra and his coworkers
79
 
showed that ROS generation can occur even in the absence of UV stimulation. 
A hint to the peculiar properties of pheomelanins in the dark was provided by a recent work 
showing that synthetic pheomelanins can behave as pro-oxidant promoting formation of 
melanin pigments from catecholamines and DOPA, a process requiring the presence of 
oxygen.
82
 
Indeed, in vitro studies with synthetic pigments indicated that both eumelanin and 
pheomelanin are able to promote DNA strand breaks in the dark,
83
 and even act as direct 
mutagenic agents by generation of CPD in the absence of UV.
47
  
The molecular basis to interpret the role of melanins in these processes was provided by in 
vitro experiments showing that, in the dark and in the presence of oxygen, natural and 
synthetic pheomelanins can accelerate depletion of two cellular antioxidants, namely 
glutathione (GSH) and reduced nicotinamide adenine dinucleotide (NADH), by a UV-
independent mechanism.
84
 High pressure liquid chromatography (HPLC) analysis with 
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electrochemical and/or UV detection allowed to observe the generation of GSH disulfide 
(GSSG) and NAD
+
, confirming a redox reaction. Natural eumelanin from black hair induced 
less marked variations. The same study showed that natural pheomelanin is able to promote 
the oxidation of melanin precursors, for example DOPA and 5SCD, in the dark. Data from 
EPR experiments suggested that pheomelanin can promote GSH and NADH autoxidation via 
direct H-atom exchange. The subsequent reoxidation of reduced pheomelanin by oxygen may 
generate ROS and restore the free-radical population, thus sustaining a redox cycle.
84
 
However, neither the effects of melanins at cellular level, nor the possibility that the pigment 
may display a proinflammatory activity, have been investigated. 
Based on this background, part of the research activity of this PhD project was focused on 
testing the ability of natural melanins to induce an inflammatory response on cultured 
keratinocytes and to affect the levels of endogenous antioxidants, independently from light 
exposure. 
In order to examine human hair pheomelanin redox properties, a sample of the pigment was 
provided to Professor Payne of the University of Maryland for its evaluation in an  
electrochemically-based reverse engineering methodology. Moreover polycysteinyldopamine 
(pCDA), a red hair-inspired polydopamine-like polymer, was tested for the ability to 
accelerate the autoxidation of GSH via a redox exchange process.  
2.2 Light-independent effects of purified human hair melanins on keratinocyte cell 
cultures 
Immortalized keratinocytes were incubated by Dr. Roberta Di Caprio (University of Naples) 
and Dr. Serena Lembo (University of Salerno) in the dark with increasing doses of red hair 
pheomelanin (RHP), black hair eumelanin (BHE) and white hair protein (WHP), purified 
from untreated hair of healthy volunteers.
85
 
Pigments from hair have been widely used as a model for human melanin. It is preferable to 
use freshly collected hair samples, as photoaging induces structural modifications not only in 
pheomelanins
28
 but also in eumelanins.
86
  
Isolation of natural melanin pigments represents quite a difficult task because of the close 
association of proteins and other biological components with melanin.
85,87,88 
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Melanin in human hair is deposited in the form of granules in the medulla, the porous core of 
the hair fiber and in the cortex surrounding it. Access to the inside of the hair by a proper 
swelling of the overlapping layers of the external covering, the cuticle, is therefore necessary 
for pigment release. Current strategies revolve on the attack of the keratin matrix by breaking 
disulfide bonds and exposure to proteolytic digestion.
89
 The enzymatic extraction preserves 
the integrity of the melanosome, removes most of the external proteins, and therefore should 
be the preferred choice for isolation of melanin from hair samples.
87
  
Homogenization of the finely minced hair sample is required prior to exposure to proteolytic 
agents to favor their action. This can be achieved by the use of a glass/glass potter such as 
Tenbroeck homogenizer while other mechanical devices (grinder, ultrasonic disrupters) 
currently employed for tissue homogenization prove often inappropriate.  
Hair was treated with dithiothreitol and subjected to different digestion steps with proteinase 
K. Every digestion step was followed by centrifugation: the pellet was collected and the 
supernatant was acidified to allow formation of a precipitate that was combined with the 
former. The reaction mixture was eventually treated with Triton X-100 for improving proteins 
solubilization and removal from the pigment. The overall procedure represented in Figure 3 
afforded 125 mg starting from 5 g of red hairs. The same protocol repeated on black hairs 
yielded 157 mg of black hair melanin and 65 mg from white ones. 
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Figure 3. Schematic outline of the procedure of pheomelanin isolation from human hair. 
Chemical analysis was carried out on the starting hairs and the final purified pigment to assess 
the degree of pigment enrichment. Degradation of the pigmented tissues by alkaline hydrogen 
peroxide treatment was followed by HPLC quantitation of the typical structural markers, 
namely thiazole-2,4,5-tricarboxylic acid (TTCA) for pheomelanin, and 2,4,5-pyrrole-
tricarboxylic acid (PTCA) for eumelanin.
90
     
Purified red human pheomelanin (RHP) showed an 11-fold enrichment in melanin with 
respect to the starting hair based on the yields of TTCA. The pigment content in RHP was 
also estimated as 57% by EPR analysis from the ratio of the double integration of the RHP 
and a synthetic pheomelanin from 5SCD (CD-mel) spectra. In the case of BHE a 10 fold 
enrichment was estimated based on the yields of PTCA.  
Exposure to RHP or BHE, but not to WHP, moderately decreased keratinocyte viability 
compared to untreated control cells (Figure 4). Proliferation/apoptosis assessment showed not 
significant differences.  
Hair (5 g) is washed with organic solvents to 
remove sebum, cut in little pieces, 
homogenized and suspended in 0.1 M 
phosphate buffer (pH 7.4)
a) dithiothreitol (625 mg)
b)dithiothreitol (600 mg), Proteinase K (40mg)
• Centrifugation step (*)
c) dithiothreitol (600 mg), Proteinase K (40 mg)
• Centrifugation step (*)
d) dithiothreitol (360 mg), Proteinase K (24 mg)
• Centrifugation step (*)
e) dithiothreitol (8.4 mg), Proteinase K (2 mg)
• Centrifugation step (*)
f) dithiothreitol (12.6 mg), Proteinase K (3 mg)
• Centrifugation step (*)
(*) After each centrifugation 
step, pellet was collected, 
supernatant acidified  and 
centrifuged again.
37  C, 
under stirring, overnight
Treatment of the pellet with Triton (37  C, 4h, 
under stirring)
Centrifugation step (*)
Digestion with Proteinase K (12.6 mg) and 
dithiothreitol (83 mg)
Centrifugation step (*)
Lyophilization of pellet
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Figure 4. Viability of HaCat cells after exposure to multiple concentrations (0.005; 0.05; 0.5 
mg/mL) of RHP, BHE or WHP for 24 hours. Data are expressed as mean ± SD of three 
independent experiments, each performed in duplicate (*p<0.05; **p<0.01; ***p<0.001). 
The direct pro-inflammatory ability was investigated through IL-1β, TNF-α and IL-6 gene 
(RT-PCR) and protein expression (ELISA). IL-1 is one of the most potent proinflammatory 
mediators and elevated levels of IL-1β have been correlated with melanoma progression; IL-6 
(formerly known as BSF-2 and IFN-) is a pleiotropic cytokine that participates in 
immunomodulation, hematopoiesis, inflammation, and oncogenesis; it is produced by many 
cell types, including keratinocytes, and stimulates proliferation in keratinocytes, being 
essential for wound healing.
91
 TNF- (formerly cachectin) is involved in multiple cellular and 
inflammatory immune reactions through activation of corresponding receptors. While IL-1β 
upregulates MC-1R activity and message, TNF- has the opposite effect.92   
RHP, and to a minor extent BHE, promoted expression of pro-inflammatory interleukins and 
oxidative damage, whereas WHP was ineffective. More in detail, after 24 hours, gene 
expression increase was dose related (Figure 5 a-c) and highly significant for TNF- α and IL-
1β (Figure 6a), whereas protein secretion of IL-6 resulted more enhanced than that of TNF- α 
or IL-1β (Figure 6b). No significant differences in protein expression emerged at 48 hours.  
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Figure 5. Dose–response curve for TNF- (a), IL-1 (b) and IL-6 (c). Data are expressed as 
mean ± SD of three independent experiments, each performed in duplicate (*p<0.05; 
**p<0.01; ***p<0.001). 
 
 
Figure 6. TNF-α and IL-1β gene expression (a) and protein expression (b) in the absence 
(Ctrl) or in the presence of RHP, BHE or WHP. Data are expressed as mean ± SD of three 
independent experiments, each performed in duplicate (*p<0.05; **p<0.01; ***p<0.001). 
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The discrepancy between IL-6 gene expression and protein secretion is likely due to an early 
rise of mRNA, which has already decayed after 24h, when protein has accumulated, also 
inducing TNF-α negative regulation. TNF-α, IL-1β and IL-6 were studied as pivotal 
mediators of chronic inflammation, implicated in most stages of tumorigenesis. Although 
their role is still controversial, up-regulation has been reported in melanoma, also in relation 
to inflammasome activation, occurring in response to pathogens associated molecular patterns 
(PAMPs) or (damage associated molecular patterns) DAMPs.
11,12,93
  
Pheomelanin can act as a binding agent for drugs and chemicals.
94,95
 Thus the long, melanized 
scalp hair with its capability to trap and/or bind chemicals, toxins, and heavy metals would 
prevent their access to living tissues. Pigmented hair may also provide antioxidant defense for 
the skin and hair follicles due to the high capacity of melanin for binding transition metals. 
This buffering capacity as applied to calcium would imply a role for melanin in cell function, 
since calcium is a critical second messenger in pigmentation signaling, acting in the transfer 
of melanosome to keratinocytes, and in epithelial cell differentiation.
96
  
In order to ensure removal of possible contaminants that could affect the results so far 
illustrated, integrative experiments with the 3 compounds (RHP*, BEH*, WHP*) previously 
washed with EDTA, a strong chelating agent, have been performed to ensure removal of 
drugs or other substances possibly derived from environmental contamination. No significant 
differences in terms of toxicity or pro-inflammatory effects were obtained for the EDTA-
treated compounds with respect to the untreated ones (data not shown). 
 In order to explore the direct pro-oxidant ability of RHP, BHE and WHP, the levels of 
cellular antioxidants and lipid peroxidation markers were determined. 
The effect of RHP on the autoxidation of GSH, a primary cellular antioxidant, a substrate for 
detoxifying enzymes such as glutathione-S-transferase and glyoxalase, and a cofactor of 
glutathione peroxidase, and NADPH, a central component of the respiratory chain and a 
critical index of the metabolic state of the mitochondria in terms of energy production and 
intracellular oxygen levels
97
 was investigated. 
Pheomelanin pigments are generated within the melanosomes, organelles that contain the 
biochemical machinery for production of pigments. Hair pheomelanosomes are less regularly 
shaped than eumelanosomes.
98–101
 Once pheomelanosomes are mature, they are transferred to 
keratinocytes, where they are made available to come into contact with major cellular 
ingredients including GSH, NADH and other redox active biomolecules. Thus, both in 
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melanocytes and keratinocytes, the pigment components of pheomelanosomes, which seems 
to be more accessible than those of the compact eumelanosomes, can induce a depletion of 
cellular antioxidants at micromolar concentrations. Moreover, it is possible that ROS 
produced by interaction between pheomelanin and GSH, damage the pheomelanosome 
surface favoring the contact of the pigment with the antioxidants. 
The level of GSH was determined by HPLC with electrochemical detector set at +500 mV vs. 
an Hg/Hg2Cl2 reference electrode while in the case of NADPH a UV detector was used 
(wavelength set at 340 nm). Depletion of either the antioxidants was observed after exposure 
to RHP and, to a lower extent, to BHE (Figure 7a). These results are in line with the effects of 
RHP on GSH and NADPH levels, in air equilibrated metal-free buffer.
84
 
Moreover, thiobarbituric acid reactive substances (TBARS) assay was performed. This 
spectrophotometric assay  allows to determine and quantify malondialdehyde (MDA) and 
related compounds, known to be byproducts of lipid peroxidation.
102
 MDA can denature 
proteins, alter apoptosis, and influence the release of proinflammatory mediators, such as 
cytokines, foster the induction of some inflammatory skin diseases.
103
 An increase of TBARS 
was registered after exposure to RHP and, to a lower degree, to BHE (Figure 7 b). However, 
as not all lipid peroxidation products generate MDA and MDA is not the only product of fatty 
peroxide formation, care should be taken in interpreting results from TBARS assay that can 
only offer a narrow picture of the process of lipid peroxidation. 
 
Figure 7. Levels (expressed as percent of control) of GSH and NADPH levels in keratinocyte 
cultures after 24 hours exposure to RHP, BHE and WHP (0.5 mg/mL) in the dark (a). Levels 
(expressed as percent of control) of thiobarbituric acid reactive substances (TBARS) after 24 
hours (b). WHP. Data are expressed as mean ± SD of three independent experiments, each 
performed in duplicate. 
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Oxidative stress plays a key role in several inflammatory skin diseases and a correlation 
between inflammation and cancer has been established.
104,105
 As a cross-point between the IL-
1β inflammatory pathway and the direct oxidative damage, the expression of cyclooxygenase-
2 expression (COX-2) gene was then determined. IL-1β increases COX-2 that is not 
expressed in normal cells but is increased in melanoma.
106
 Exposure to RHP for 24 h in the 
dark was found to induce a moderate but significant increase of COX-2 expression (Figure 8).   
 
Figure 8. COX-2 gene expression in HaCat cell in the absence (Ctrl) or in the presence of 0.5 
mg/mL of RHP, BHE or WHP. Data are expressed as mean ± SD of three independent 
experiments, each performed in duplicate (*p<0.05; **p<0.01; ***p<0.001). 
2.3 Pro-oxidant properties of polycysteinyldopamine thin films 
Polycysteinyldopamine (pCDA) is a red hair-inspired polydopamine-like polymer
107
 derived 
by the oxidation of 5-S-cysteinyldopamine (CDA). In turn, CDA is an important building 
block of neuromelanin, a pigment found mainly in the substantia nigra of central nervous 
system. 
108,109
  
CDA oxidation generates benzothiazine intermediates similar to pheomelanin building blocks 
by the cyclization of cysteinecatechol conjugates derived from attack of cysteine onto o-
quinone intermediates. 
CDA was prepared by a chemical reaction between dopamine (DA) and cysteine, according to 
a previously reported method
110
 that allows to produce a polymer containing benzothiazine 
units similar to those found in photoactive red hair pigments. 
CDA thin film prepared by Dr. Mariagrazia Iacomino (University of Naples) allowing the 
polymer (10 mM) to autoxidize in bicarbonate buffer (50 mM, pH 8.5) in the presence of 
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quartz and glass cuttings. The thin films obtained were characterized by scanning electron 
microscopy (SEM), tapping mode atomic force microscopy (AFM) analysis and X-ray 
photoelectron spectroscopy (XPS) as reported.
107
 
The ability of pCDA thin films and suspensions to affect autoxidation of GSH and NADH 
was tested. Data reported in Figure 9 show that both the suspension and the films can 
accelerate the autoxidation of GSH and NADH in phosphate buffer (pH 7.4), reaching 80% of 
GSH depletion in less than 3 h.   
 
Figure 9. Effect of pCDA on the autoxidation of GSH at 150 mM (a) and NADH at 300 mM 
(b) at 3 h reaction time in 0.1 M phosphate buffer pH 7.4 as determined by HPLC-ED/UV. 
Data are expressed as mean ± SD of three independent experiments, each performed in 
duplicate.  
In control experiments using pDA the reaction rate was not significantly affected (data not 
shown). This accelerating effect was not observed under an argon atmosphere, pointing out an 
essential role of oxygen. Data are in line with the effects of RHP on GSH and NADPH levels, 
in air equilibrated metal-free buffer,
84
 suggesting a redox cycle. 
2.4 Pheomelanin pro-oxidant properties: a mechanism from reverse engineering 
Another hint suggesting that pheomelanins may contribute to sustaining a chronic oxidative 
stress condition through a redox buffering mechanism comes from experiments conducted by 
an electrochemically-based reverse engineering methodology that allows to characterize the 
functionality of complex technological and biological systems.
111
 Pheomelanins and 
eumelanins pigments isolated from human hair as well model synthetic pigments prepared by 
enzymatic oxidation of dihydroxyphenylalanine (DOPA) or 5SCD were provided to Professor 
Gregory F. Payne (University of Maryland) to test their redox activities. 
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Melanin samples were exposed to complex voltage inputs and output responses were 
measured. Here is summarized the electrochemical methodology that has been applied: 
1) An insoluble melanin sample was entrapped in a non-conducting hydrogel film and 
was localized near an electrode. 
2) Soluble mediators shuttled electrons between the sample and the electrode.
112
  
3) Complex input voltages are applied and the potentials were transmitted to the samples 
through the soluble mediators. 
4) Output currents are measured and analyzed to assess melanin redox activity.113,114  
 
First model melanins were examined and the results show that even if both eumelanin and 
pheomelanin are redox-active and can engage in redox-cycling reactions, pheomelanin 
possess a more oxidative redox potential. Even in the case of natural melanins, a grater 
pro-oxidant activity is displayed by pheomelanins with respect to eumelanins, suggesting 
that a redox buffering mechanism is involved in their pro-oxidant activity. 
 
 
Figure 10. Scheme of the electrochemical approach to reverse engineer melanin: soluble 
mediators shuttle electrons between electrode and sample. Complex input voltages are 
applied while output currents are measure (adapted from Kim et al. 2015).
115
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CHAPTER 3 
3.1 Eumelanin pigments: (photo)protective properties and the origin of the 
broadband absorption spectrum 
Eumelanin synthesis is associated with functionally active melanocortin-1-receptor (MC1R),
1
 
whose function is regulated by the physiological agonists αMSH and adrenocorticotropic 
hormone (ACTH) and by one antagonist agouti-signaling protein (ASP). 
In wild-type eumelanic subjects, α-MSH stimulates MC1R activating the associated G- 
protein, which in turn activates adenyl cyclase and increases the levels of cellular cyclic 
adenosine 3’,5’-monophosphate (cAMP), responsible for tyrosinase and tyrosinase-related 
protein-1 and -2 activity.
116,117
 
The photoprotective role of eumelanin is commonly accepted however this not restricted to a 
radiation filtering action, but includes scavenging of free radical species by the pigment itself 
or its precursors resulting in an antioxidant effect.
60,85,118–124
  
Photoprotection and antioxidant properties are closely related biological aspects: actually, 
oxidative stress, especially if UV induced, is one of the main determinants in carcinogenesis. 
MC1R and its ligand are also involved in regulation of homeostatic skin function,
117
 redox 
equilibrium
74,125,126
 and conservation of genomic integrity.
127–130
 In addition, -MSH is able 
to decrease intracellular levels of H2O2,
74,131,132
  to repair DNA photoproducts
10,74,125,133,134
 and 
to phosphorylate p53 in UVR-irradiated melanocytes. Phosphorylation activates p53 reducing 
the generation of ROS that could damage the DNA and regulating the expression of enzymes 
involved in base excision repair (BER).
127,129
 
The supramolecular structure of eumelanin has been investigated by several studies
87,135–141
 
and determines the features of this pigment, including the already mentioned photoprotective 
and antioxidant properties but also the UV energy dissipation mechanism,
120,142
 the water 
dependent ionic-electronic conductivity,
143
 and the stable paramagnetic state resulting in a 
signal in the EPR spectroscopy.
2,144,145
 
Most importantly, eumelanins display a broadband absorption spectrum with monotonic 
wavelength dependence and are able to absorb light and to convert the energy of the absorbed 
photon in non-photochemical processes. However, the molecular and cellular mechanism of 
action is not fully explained.
60,146
  
The pigment is generally regarded as a heterogeneous polymer of DHI and DHICA linked 
through diverse bonding patterns
147,148
 that confers the pigment a degree of disorder that 
extends to various levels (Figure 11).  
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Figure 11. Main levels of eumelanins disorder. 
The first level is the chemical disorder
149
 related to the different coupling mode of DHI and 
DHICA leading to a variety of oligomeric species that can develop complex ensembles of 
chromophores spanning the entire UV-visible range.   
Electronic disorder instead derives from the coexistence of oxidized and reduced moieties that 
is essential for the broadband visible-light absorption spectrum, as suggested by data from 
glycated water soluble eumelanin.
150
 According with this study, black color would depend not 
only on the overlap of π-electron conjugated chromophores151,152 but even on oxidation state- 
and aggregation-dependent interchromophoric interactions. 
The use of poly(vinyl alcohol) (PVA) to prevent eumelanin precipitation
135
 allowed to 
disentangle absorption properties due to chromophore from scattering effects, pointing out 
that beside the intrinsic chromophore component there is an extrinsic contribute that depend 
on intermolecular perturbation
153
 of -electron systems and that is dominant in DHICA 
melanin, because of the lack of planar conformation.
144,154
 
These intrinsic and extrinsic contributes (Figure 12), together with the interaction of 
geometric order and disorder, would cooperate to generate the absorption spectrum of 
eumelanin.
155–158
 
 
Figure 12. Intrinsic and extrinsic contributions to eumelanin absorption properties. 
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Computational studies suggested that the monotonic spectrum of eumelanin is due to 
delocalization of excitons over stacked DHI melanin.156,157 The current view is that the optical 
eumelanin properties can be mimicked only by including catechol, semiquinone and quinone 
building blocks.159  
In order to provide structure-properties relationships underlying the band broadening 
spectrum and to elucidate the contributions of the different levels of disorders, part of this 
thesis was directed to investigate and compare a broad collection of eumelanin precursors 
featuring different substituents, molecular size (monomers and dimers) and shape (isomeric 
dimers). 
The dynamics of band broadening during eumelanin chromophore buildup and the role of 
chemical disorder were addressed by combining spectrophotometric experiments with 
computations. In particular, two contributions to chemical disorder were considered: 
structural disorder, reflecting the variety of -scaffolds, and redox disorder, as determined by 
catechol-semiquinone-quinone mixing and -electron perturbations. 
3.1.1 The dynamics of eumelanin chromophore evolution 
The shielding effect of eumelanin is achieved by its ability to serve as a physical barrier 
against UVR that reduces the penetration of UV through the epidermis.
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On this basis, the development of a picture of the nature and interaction mechanism of 
individual chromophores underlying eumelanin UV-visible spectrum is of general interest 
because of its relevance to dissect crucial structure-properties-function relationships. 
In order to reach this aim, preliminary experiments were directed at comparing the generation 
and evolution of chromophores from DHI in the presence and in the absence of 1% PVA, a 
hydrophilic polymer able to prevent melanin precipitation. 
Three oxidizing systems have been used: 
 potassium ferricyanide in phosphate buffer at pH 7.0,  K3[Fe(CN)6], operating by an 
outer sphere one-electron transfer mechanism (2 molar eq.) 
 sodium periodate in phosphate buffer at pH 7.0, NaIO4, operating by the induction of 
two –electrons oxidations via cyclic esters with catechols (1 molar eq.) 
 ceric ammonium nitrate (CAN) in phosphate buffer at pH 3.0, (NH4)2[Ce(NO3)6], 
operating by a one-electron transfer mechanism (2 molar eq.) 
Oxidant concentration was based on a two-electron oxidation stoichiometry relative to the 
monomer, formally corresponding to o-quinone formation. Monomer consumption was 
checked by HPLC and was complete under these reaction conditions. 
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Ferricyanide and periodate induced similar chromophoric changes and evolution kinetics 
while CAN induced a less intense chromophore, possibly ascribable to the inhibition of 
deprotonation at acidic pH (Figure 13). 
 
 
Figure 13. Generation of chromophores from DHI (50 M) using different oxidizing systems: 
potassium ferricyanide in phosphate buffer, pH 7.0, sodium periodate in phosphate buffer at 
pH 7.0 or ceric ammonium nitrate (CAN) in phosphate buffer at pH 3.0. 
Ferricyanide was selected as the oxidant and oxidations were carried out with DHI and other 
selected monomers and dimers (Figure 14) at 50 M concentration. 
 
Figure 14. Structures of monomers and dimers investigated in this thesis. 
Data from DHI oxidation over 24 hours reaction time showed the generation of a broad 
visible chromophore around 560 nm, named melanochrome, according to an old nomenclature 
(Figure 15).16 
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Further addition of 2 molar equivalents of potassium ferricyanide did not affect the maximum 
intensity and the persistence of the chromophore suggested the occurrence of oxidation 
processes unrelated to chromophoric species. 
 
Figure 15. Generation and evolution of chromophores from DHI (50 M) oxidation by 
ferricyanide (2 molar equivalents) in the absence or the presence (b) of 1% PVA. 
In order to quantify scattering contributions to the final spectra, spectra were recorded before 
and after filtration through a 0.45 micron nylon membrane. Spectra showed that at 5 min the 
maximum was not detectable in the spectrum of the filtrate. 
The oxidation mixtures slowly darkened both in air and under an argon atmosphere due to 
broadening of the absorption band accompanied by extensive precipitation, as measured by 
filtration at 24 h. In the presence of 1% PVA melanin precipitation was inhibited at least in 
part, but melanochrome formation proceeded in a similar manner (Figure 16). 
 
Figure 16. UV-vis spectra of DHI (50 M) oxidation mixtures by ferricyanide (2 molar 
equivalents) in the absence and in the presence of 1% PVA. Green traces were recorded 
before filtration, brown traces were recorded after filtration.  
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We can identify three phases of the chromophore generation and evolution: 
I) Fast generation of the melanochrome, whose absorption is mainly due to intrinsic 
chromophores.160 
II) Slow band broadening process, mainly due to extrinsic contributions (i.e. 
intermolecular chromophore perturbations) 
III) Melanin precipitation and consequent scattering. 
While Phase I depends on the presence of the oxidant, phase II is oxygen independent. PVA 
allowed to disentangle contribution from phases II and III that would be otherwise 
superposed. 
Digital pictures in Figure 17 show the gradual darkening of the oxidation mixtures and the 
deposition of melanin pigment. At 5 min, it was possible to observe the development of a 
bluish coloration due to the melanochrome. These comparative pictures allow to evaluate the 
effects of the presence of PVA on phase III. 
 
Figure 17. Digital pictures of the oxidation mixtures obtained by ferricyanide oxidation of 
DHI (500 M) over 24 h in the absence and in the presence of 5% PVA. 
In order to examine the effect of ring substituents on the dynamics of DHI polymerization, the 
same experiment was performed on N-methyl derivative of DHI (N-MeDHI), DHICA and 
MeDHICA.. 
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The effect of the methyl group is negligible and the spectra are similar in case of DHI and N-
MeDHI (Figure 18). 
 
Figure 18. Generation and evolution of chromophores from N-MeDHI (50 M) oxidation by 
ferricyanide (2 molar equivalents) in the absence or in the presence of 1% PVA. 
In the case of DHICA a deep violet chromophore broadly centered between 500-550 nm and a 
well-defined UV absorbing band around 330 nm were observed both in the presence and in 
the absence of PVA (Figure 19). Spectra recorded at 5 min and 2 h showed that the inhibition 
of aggregation due to PVA delayed the decay of melanochrome. 
 
Figure 19. Generation and evolution of chromophores from DHICA (50 M) oxidation by 
ferricyanide (2 molar equivalents) in the absence or in the presence of 1% PVA. 
Digital pictures before and after filtration, in the presence and in the absence of PVA, 
confirmed the role of aggregation in color development (Figure 20). 
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Figure 20. Digital pictures of the oxidation mixtures obtained by ferricyanide oxidation of N-
MeDHI or DHICA (500 M) over 24 h in the absence and in the presence of 5% PVA. 
Differently from what observed in the case of DHICA, ferricyanide oxidation of MeDHICA 
did not lead to chromophores in the visible region nor appreciable rise of scattering (Figure 
21).  
 
Figure 21. Generation and evolution of chromophores from MeDHICA (50 M) oxidation by 
ferricyanide (2 molar equivalents) in the absence or in the presence of 1% PVA. 
The lack of aggregated unsoluble materials was also confirmed by filtration that did not 
induce substantial modification of the chromophore intensity (Figure 22). 
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Figure 22. Digital pictures of the oxidation mixtures obtained by ferricyanide oxidation of 
MeDHICA (500 M) over 24 h in the absence and in the presence of 5% PVA. 
A complete set of the UV spectra recorded for N-MeDHICA, DHICA and MeDHICA is 
shown in Figure 23-25. 
 
Figure 23. UV-vis spectra of N-MeDHI (50 M) oxidation mixtures by ferricyanide (2 molar 
equivalents) in the absence and in the presence of 1% PVA. Green traces were recorded 
before filtration, brown traces were recorded after filtration. 
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Figure 24. UV-vis spectra of DHICA (50 M) oxidation mixtures by ferricyanide (2 molar 
equivalents) in the absence and in the presence of 1% PVA. Green traces were recorded 
before filtration, brown traces were recorded after filtration. 
 
 
 
Figure 25. UV-vis spectra of MeDHICA (50 M) oxidation mixtures by ferricyanide (2 molar 
equivalents) in the absence and in the presence) of 1% PVA. Green traces were recorded 
before filtration, brown traces were recorded after filtration. 
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3.1.2 The role of structural disorder 
In order to assess the effect of molecular disorder, depending on molecular weight dispersion 
and molecular diversity, the course of oxidation of dimers was examined and compared to that 
of the corresponding monomers. 
The molecular weight dispersion was decreased by the use of dimers as substrate, as only 
even-numbered oligomers are possible under these conditions. 
The variety of scaffolds produced within each oligomer population was lower because of the 
inherent constraint posed by the interring bond. 
The chromophores generated in the first phase by the isomeric 2,4’-, 2,7’- and 2,2’-dimers of 
DHI both in the presence and in the absence of PVA were different (Figure 26).  
 
 
Figure 26. UV-vis spectra of  2,2’-, 2,4’- and 2,7’-dimers of DHI (50 M) oxidation mixtures 
by ferricyanide (2 molar equivalents) in the absence and in the presence of 1% PVA. 
The almost overlapping traces recorded at 5 min, 2 h and 24 h in the absence of PVA, suggest 
that the evolution of the melanochrome is faster in the case 2,2’- dimer. It is so reasonable that 
the way the indole units are bound is more important than the decrease of molecular weight 
dispersion and this influence is stronger in the first phase of the chromophore evolution.  
Comparing the spectra of the oxidation mixture of 4,4’-DHICA dimer with those of the 
relative monomer, it appears that the melanochrome evolution is faster (Figure 27). Similar 
was also the course of the oxidation of the 4,4’–dimer compared to the monomer (not shown).  
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Figure 27. Generation and evolution of chromophores from 4,4’-DHICA (50 M) oxidation 
by ferricyanide (2 molar equivalents) in the absence or in the presence of 1% PVA. 
A complete set of the UV spectra recorded for 2,4’-, 2,7’- and 2,2’-dimers of DHI and for the 
4,4’-dimer of DHICA is shown in figures 28-31. 
 
 
Figure 28. UV-vis spectra of  2,2’-dimers of DHI (50 M)  oxidation mixtures by ferricyanide 
(2 molar equivalents) in the absence (a) and in the presence (b) of 1% PVA. Green traces 
were recorded before filtration, brown traces were recorded after filtration. 
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Figure 29. UV-vis spectra of  2,4’-dimers of DHI (50 M) oxidation mixtures by ferricyanide 
(2 molar equivalents) in the absence (a) and in the presence (b) of 1% PVA. Green traces 
were recorded before filtration, brown traces were recorded after filtration. 
 
 
Figure 30. UV-vis spectra of  2,7’-dimers of DHI (50 M) oxidation mixtures by ferricyanide 
(2 molar equivalents) in the absence and in the presence of 1% PVA. Green traces were 
recorded before filtration, brown traces were recorded after filtration. 
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Figure 31. UV-vis spectra of 4,4’-dimer of DHICA (50 M)  oxidation mixtures by 
ferricyanide (2 molar equivalents) in the absence (and in the presence of 1% PVA. Green 
traces were recorded before filtration, brown traces were recorded after filtration. 
To compare the shapes of the final spectra of the dimers with those of the monomers, 
absorbance data at fixed visible wavelengths were normalized against the UV band at 300 nm 
and the resulting traces were matched against the theoretical monotonic profile (Figure 32). 
 
Figure 32. Relative absorbance of the oxidation mixtures of the indole compounds at 24 h 
over the UV-visible region in the absence (left) and in the presence of 1% PVA (right). Values 
normalized against the absorbance at 300 nm for each mixture.  
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DHICA and its dimer show a similar trend while the traces for DHI and its dimers are 
different, with more marked differences in the presence of PVA. The intensity of the visible 
chromophore decrease in the order 2,4’- > 2,2’- > 2,7’-isomers. 
To complete the picture of eumelanin formation, the course of oxidation mixtures of 3,4-
dihydroxyphenylalanine (DOPA) and dopamine (DA) were investigated. Since DHI and 
DHICA are produced from these catecholamines precursors by a 4-electrons oxidation 
process, 6 molar equivalent of potassium ferricyanide were used (Figure 33). These 
absorption profiles substantially lack the  maximum due to melanochrome formation. The 
absorption in the visible range for DA is lower  compared to DOPA, on account of its lower 
tendency to cyclize. The absorption maximum at around 420 nm observed in the spectra taken 
at 5 min is due to residual ferricyanide. 
 
 
Figure 33. Generation and evolution of chromophores from DOPA or DA (50 M)  oxidation 
by ferricyanide (6 molar equivalents) in the absence or in the presence of 1% PVA. 
 
Formal extinction coefficients (f),  were determined at 450, 550 and 650 nm for the 
chromophores produced at different reaction times in the presence of PVA.  
 
f = A/lc 
 
(A is the absorbance, c is the initial monomer concentration and l is the optical path in cm) 
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 Table 1. Formal extinction coefficients at different 
wavelengths and reaction times of the eumelanin 
chromophores investigated. 
 
Precursor 
(50M) 
 
f 
(450) 
 
f 
(550) 
 
f 
(650) 
f  ratio 
550/450 
f ratio 
650/550 
5 min 
DHI 2460 2909 2343 1.18 0.81 
DHICA 1788 2618 1176 1.46 0.45 
DOPA 3059 1267 256 
 
0.41 0.20 
DA 2589 
 
1419 440 
 
0.55 0.17 
2 h 
DHI 3210 3369 2787 1.05 0.83 
DHICA 1957 1990 1212 1.02 0.61 
DOPA 3106 2478 
 
1956 
 
1.62 0.79 
DA 1529 
 
661 
 
306 
 
0.43 0.20 
24 h 
DHI 3423 2603 1467 0.76 0.56 
DHICA 2304 1493 705 0.65 0.47 
DOPA 4042 2441 
 
1316 
 
 
 
0,60 0.54 
DA 1915 967 
 
344 
 
0.50 0.36 
a) DHI melanin exhibits higher formal extinction coefficients than those of DHICA 
melanin at 650 nm. 
b) 650/550 nm coefficient ratios for DHICA are invariably lower than for DHI at each 
time; 
c) 550/450 nm and 650/550 nm ratios at 5 min, show respectively higher and lower values 
in the case of DHICA compared to DHI. This can be considered an index of 
melanochrome intensity and it is  consistent with a more defined band shape.  
d) The 550/450 nm coefficient ratio decreases passing from 5 min to 2 h while 650/550 nm 
ratio increases. This can considered an index of band broadening. 
 
Lower extinction coefficient at 5 min at 550 nm than DHI confirms the important role of the 
carboxyl group in DHICA in inhibiting the development of the visible chromophore at all 
three phases. Moreover, DHICA chromophore is more defined than that of DHI. 
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3.1.3 The role of redox disorder 
The possible occurrence of each structural component at different oxidation levels would 
imply a redox disorder. If we consider a dimer, each isomer can exists in the entire gradational 
range of redox states comprised between the fully reduced (4 H) species and the oxidized 
fully quinonoid species (0 H), so n+1 redox species (with n = number of OH groups) are 
possible. 
Experiments aimed at probing susceptibility of eumelanin final chromophore to modification 
by oxidant or reducing oxidant, can give indirect information about the average redox state 
The addition of sodium dithionite or sodium borohydride to eumelanin samples produced in 
the presence of PVA caused a detectable decrease in the visible absorption (Figure 34).  
 
 
Figure 34. Effect of addition of sodium dithionite or sodium borohydride to the oxidation 
mixtures of DHI or DHICA in the presence of 1% PVA. 
Despite the failure to attain complete color suppression, quinonoid species seem to be 
important determinants of the visible chromophores. It is worth noting that the PVA chain 
coin could hindered the action of the reductant so separate experiments carried out in the 
absence of PVA using an excess of reductant agents,  showed comparable decrease of the 
absorption in the visible region.  
Acidification to pH 2 caused a detectable ipsochromic shift of the visible chromophore of 
eumelanins and a bathochromic shift of the UV band (Figure 35). Alkalinization of the 
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oxidation mixtures induced no detectable change. Chromophoric species seem to be present in 
an ionized quinonoid form at neutral pH. 
 
Figure 35. Effect of acidification on the chromophores of DHI or DHICA oxidation mixtures 
(50 M). 
These experiments overall confirmed the fundamental contribution of oxidized quinonoid 
units to eumelanin chromophore.  
In a final set of experiments eumelanin samples prepared by ferricyanide oxidation of DHI or 
DHICA were exposed to the same concentration of the relevant monomer both in the presence 
or in the absence of PVA. 
The addition of DHICA to the DHICA melanin and the addition of DHI to DHI melanin did 
not induce significant monomer conversion or chromophore change, suggesting the lack of 
redox activity for both the melanins (Figure 36). 
 
 
Figure 36. Effect of addition of DHI and DHICA at 50 M to the respective melanin 
generated in the presence of  1% PVA. 
In order to confirm the hypothesis that DHICA generates a poorly delocalized intrinsic 
chromophore and to prove the generation of extrinsic visible chromophores via intermolecular 
interaction of dimers from DHI and DHICA at different oxidation levels, computational 
studies were carried out in collaboration with the Institute of Chemistry of Organometallic 
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Compounds (ICCOM-CNR) and the Department of Chemistry and Industrial Chemistry of 
University of Pisa (Italy). 
Preliminary calculations agree with experimental data154,160 and confirm lack of visible 
absorption both in the case of DHI and DHICA monomers and dimers in the reduced catechol 
form (HQ), while the calculated spectra of the 2-electron oxidation products (Q) of DHI and 
DHICA dimers are different.  
To consider the possible role of non-covalent intermolecular interactions between the intrinsic 
chromophores157,161 a number of stacked configuration were assembled, for each of the 
investigated dimers, taking into account the coexistence150,160 and the approach to each other 
of reduced and oxidized forms.  
Three stacked conformers for each investigated species were selected  after evaluating the 
reliability and accessibility of the possible conformations and their absorption spectra 
computed at TD-DFT level.  
All Q forms  of DHI dimers exhibit intense visible bands, that is particularly evident in the 
case of the planar 2,2’ dimer (according with the evolution of chromophore in the absence of 
PVA), suggesting a strong influence of the stacking with a red-shift of main bands 
accompanied, especially at short stacking distances, by broadening and increased low-energy 
absorption. The same effect of band broadening was observed in the case of optimized 
geometry of the 2,4’-dimer. 
A remarkable effect due to stacking was predicted for the DHICA dimer. The spectrum of the 
HQ/Q complex obtained by approaching the dimers is different from the spectra of separated 
HQ and Q forms (virtually superimposable) and displays a marked bathochromic shift in the 
UV band. 
These data support the existence of stabilizing intermolecular interactions causing the 
appearance of low energy transitions in the visible range. 
As a further insight in the chromophore development from oxidation of the indoles so far 
investigated and their dimers in a further series of experiments autooxidation was run in the 
presence of some biologically relevant metal ions. The oxidation was carried out in (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) buffer at pH 7.5 in the presence of 
equimolar amounts of zinc, copper and iron ions. The course of the oxidation reaction was 
followed spectrophotometrically using the substrate at 50 M concentration (Figure 37-40). 
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Figure 37. Generation of chromophores from DHI in the presence and in the absence of 1 
molar equivalent of Zn2+ or Cu2+ or Fe3+. 
 
 
Figure 38. Generation of chromophores from N-MeDHI in the presence and in the absence of 
1 molar equivalent of  Zn2+ or Cu2+ or Fe3+. 
 
 
Figure 39. Generation of chromophores from DHICA in the presence and in the absence of 1 
molar equivalent of  Zn2+ or Cu2+ or Fe3+. 
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Figure 40. Generation of chromophores from MeDHICA in the presence and in the absence 
of 1 molar equivalent of Zn2+ or Cu2+ or Fe3+. 
Intense chromophores in the visible region are associated to the oxidation catalyzed by metal 
ions. DHI and Me-DHI gave rise to more intense absorptions in the visible range under all the 
oxidation conditions. DHICA developed a visible chromophore only in the metal catalyzed 
oxidation whereas MeDHICA did not under any oxidation condition. Differently from what 
observed with zinc, copper and iron proved able to induce the decay of all the monomers 
within a few minutes suggesting a redox exchange rather than aerobic oxidation. Purple to 
blue colors were observed for the reaction in the presence of copper in the case of both DHI 
and N-MeDHI, that are likely to arise from chelates of dimers or higher oligomers. By 
contrast in the presence of iron a brownish color prevailed. This is also well apparent in 
Figure 41 showing the colors of the oxidation mixtures in the presence of copper and iron ions 
at 10 min reaction time with the substrates at 100 M. When treated with a reducing agent as 
sodium dithionite a complete discharge of the visible chromophore was observed for both 
DHI and DHICA with either metal ions suggesting that the chromophore derive from 
quinonoid forms of dimers or oligomers possibly stabilized by the metal ions.  
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Figure 41. Color of the oxidation mixtures of DHI or DHICA in the presence of equimolar 
metal ions with the substrate at 100 M  Left: at 10 minutes reaction time; Right: soon after 
addition of excess dithionite.  
A comparison of the course of the oxidation of monomers versus dimers for N-MeDHI, DHI 
and MeDHICA is shown in Figure 42. As representative dimers, the 2,2’- and 2,7’-biindolyl 
were chosen for DHI and the 4,4’-isomer for Me-DHICA.  
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Figure 42. Oxidation mixtures of 0.25 mM dimers of DHI and Me-DHICA under different 
reaction conditions, namely 1 min ferricyanide oxidation in the presence or in the absence of 
5% PVA and metal catalyzed 10 min oxidation.   
These experiments indicate that the presence of metal ions is an important determinant of 
transient and final chromophores and color properties. Redox active metals can induce rapid 
formation of visible chromophores likely due to quinonoid dimer/oligomer species that 
survive in the reaction mixture thanks to the stabilization provided by metal chelation.  
3.2 Antioxidant and other biological properties of indole precursors with special 
reference to     DHICA 
Besides eumelanin pigments, the entire eumelanogenic pathway is relevant to melanocyte 
function.
162
 While in vitro eumelanin synthesis envisages the spontaneous decarboxylation of 
dopachrome to DHI,
163
 in vivo the intervention of the enzyme dopachrome tautomerase (Dct 
or tyrosinase-related protein Tyrp 2) directs eumelanin synthesis to the formation of 
DHICA.
35,154,164
 The outcome is that while synthetic eumelanin contain about 10% of 
DHICA-derived units, natural eumelanin is made up of more than 50% of DHICA-derived 
units,165 as estimated by the ratio of 2,3-dicarboxylic acid (PDCA) to PTCA upon alkaline 
hydrogen peroxide oxidation (markers of DHI- and DHICA-derived units, respectively). 
Dct is an enzymatic protein displaying significant homology with tyrosinase and together with 
tyrosinase-related protein Tyrp 1 is involved in melanogenesis in animals. 
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This enzyme modulates melanocyte response to oxidative stress. Its expression is involved in 
increase of GSSH levels in WM35 cells, with concomitant protection from free-radical 
induced DNA damages,
166
  
Dct overexpression is associated with an increased  resistance of melanoma cells to radiation 
and conventionally used chemotherapeutics drugs
167,168
 and is related with the almost 
complete inhibition of DNA-damage induced apoptosis,
169
 representing an interesting for 
therapeutic strategies.  
Dct plays a role in the regulation of cell growth and survival of melanocytes exposed to UVB 
protecting melanoma cells from UVB-induced apoptosis. 
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Moreover investigating the effect of this tyrosinase-related protein on skin photoprotection 
and ROS scavenging capacity it has been demonstrated that Dct inactivation increases the 
level of ROS and the number of sunburn and apoptotic cells and decreases the amount of 
eumelanin in the epidermis after UV exposure.
171
  
DHICA is less oxidizable than DHI and generate a less dark pigment
35,154
 so it is difficult to 
understand why Dct causes this deviation in eumelanogenesis, increasing the ratio 
DHICA/DHI in eumelanin, suggesting that DHICA could play other roles than mere 
eumelanin precursor. 
Actually, DHICA and its main metabolite 6-hydroxy-5-methoxyindole-2-carboxylic acid 
(6H5MICA, 0.07-2.15 ng⁄mL in normal plasma)172 have antioxidant properties and play a 
critical role in melanocyte response to oxidative stress and inflammation.17  
DHICA is able to inhibit lipid peroxidation in vitro decreasing malondialdehyde (MDA) 
formation by lipid peroxidation and inhibits Fe(II)/EDTA-induced oxidation of arachidonic 
acid and MDA formation by iron-promoted degradation of 15-hydroperoxy-5,8,11,13-
eicosatetraenoic acid (15-HPETE).121 
Data from 2,2-diphenyl-1-picrylhydrazy radical (DPPH) assay show that both DHICA and its 
main metabolite are stronger antioxidant than trolox in the H-donor activity, while comparing 
the efficiency of the two indoles in reducing Fe(III) ions to Fe(II) ions using the ferric 
reducing anti- oxidant power (FRAP) assay, both DHICA and 6H5MICA proved to be better 
antioxidant than trolox (2.4 and 1.8 trolox equivalents for DHICA and its methoxy derivative, 
respectively).17 
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Nanomolar concentrations of DHICA and 6H5MICA can inhibit H2O2-Fe(II)/EDTA (Fenton)-
induced oxidation processes (IC50 = 4.3 and 6.0 nM for DHICA and 6H5MICA, 
respectively).122,123 
DHICA displays an absorption maximum in the UVB erithematogenic region (max = 313 nm) 
and can act as triplet state quencher.120,124  
When treated with increasing concentrations of the DHICA normal human keratinocytes 
(NHKs),173 undergo an inhibition of growth with no increase in mortality at any dose and time 
point tested. Quantitative real-time reverse transcriptase–PCR (qRT–PCR) shows that DHICA 
significantly enhances the expression of keratinocyte differentiation marker (namely 
involucrin, loricrin, and filaggrin), while its main metabolite 6H5MICA does not. Moreover it 
induces activity and expression of antioxidant enzymes, namely superoxide dismutase (SOD) 
and catalase, the main enzymes involved in the maintenance of the intracellular redox 
equilibrium during an oxidative stress.174 This same study shows that DHICA protects 
keratinocytes against the free-radicals–mediated damages resulting from UVA exposure.  
All these data point out that DHICA exerts an antioxidant and protective function per se 
unrelated to pigment synthesis, suggesting that the indole and/or its derivatives could play an 
important role in preventing and treating inflammatory skin pathologies related to oxidative 
stress, such as acne, atopic dermatitis and melanoma.104,175 
Moreover, it could represent a useful tool to recover the antioxidant defense pool in individual 
exhibiting red hair phenotype (RHP) who lack the protecting eumelanin pathway and suffer 
from chronic oxidative stress.81 
3.2.1 Development of bioinspired sunscreen formulations: synthesis of dioleoyl-
MeDHICA 
Excessive UVB and UVA exposure is related to sunburns, skin aging, DNA damage and 
tumorigenesis.
1
 On the other hand UV protection plays an important role in reducing the risk 
of  squamous cell carcinoma, actinic keratosis and probably also the risk of melanoma.
176
  
One of the main mechanisms of photoprotection is the absorption of the UV radiation with 
release of less harmful energy. An effective sunscreen formulation should be able to absorb 
and scatter UV radiation, to resist to photodegradation and limit photochemical damage acting 
like an antioxidant. 
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Inorganic and organic components are successfully used to protect skin from UV induced 
damages resulting in high Sun Protection Factor (SPF). Usually inorganic components, such 
as titanium dioxide (TiO2), a mineral prepared as ultra-fine nanoparticles, act as physical 
sunscreen agents by absorbing, reflecting and scattering UV radiation while organic 
compounds, such as conjugated aromatic molecules, act as a chemical sunscreen absorbing 
radiation rather than reflecting or causing it to scatter.
177
 
Unfortunately, adverse secondary effects deriving from sunscreen formulations were 
described, suggesting that their application can induce contact and photocontact dermatitis 
and photoallergic reactions.
177–180
 Moreover some sunscreen ingredients can be absorbed into 
deep layers of the skin inducing local and systemic toxicity.
181
  
Following the current trend that considers natural products the future of cosmetics, 
considerable efforts in research have been directed to the discovery and exploitation of all 
natural functional ingredients so to warrant customers safety and sustainability of the product. 
In the quest for new natural and bioinspired agents of photoprotection, DHICA, a human 
metabolite known for its anti-inflammatory and antioxidant properties (see previous 
paragraph), is suitable to be used as a protective tool against sun induced damages. 
UV radiation can penetrate deeply into the skin so topically applied photoprotective agents 
should be able to reach deeper cutaneous layers to afford the skin an effective 
photoprotection. 
In order to be able to incorporate this compound  in a formulation for topical administration, 
its lipophilicity has been increased by preparing a methyl ester at the carboxyl group and by 
the conjugation of the phenolic hydroxyl groups with a fatty acid, namely oleic acid, thus 
yielding a prodrug. 
According to the IUPAC definition, a prodrug is a “compound that undergoes 
biotransformation before exhibiting pharmacological effects”.182 The use of a conjugate of an 
active compound with a lipophilic substituent, is a good way of improve its bioavailability 
and skin permeability.
183
 
Prodrugs are often modified by esterification reactions and are more easily adsorbed into the 
outer layer of the skin, stratum corneum (the main obstacle against the penetration of 
exogenous substances through the skin), reaching the epidermis where they are hydrolyzed to 
more polar active metabolites by esterases such as carboxylesterase (CES; EC 3.1.1.1) and 
arylesterase, present both in rat and human skin.
184,185
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Oleic acid (OA) was chosen as derivatizing agent. Triglycerides of this monounsaturated 
omega-9 fatty acid compose the majority of olive oil. OA is commonly used as permeation 
enhancer and is known to increase skin permeability,
186,187
 acting on extracellular lipids that 
regulate the penetration of small molecules interacting with the lipid matrix of the stratum 
corneum. Moreover this unsaturated fatty acid can modulate inflammatory and immune 
responses in case of cutaneous wounds accelerating healing.
188
 
On this basis the synthesis of the highly lipophilic ester of  DHICA methyl carboxylate with 
oleic acid was performed, adapting an already developed  procedure.
189
 Oleoyl chloride was 
used instead of free OA as a more reactive acylating agent.  
Spectral characterization of the product confirmed the expected structure. 
The lipophilic product was incorporated in Vaseline (5% w/w) by standing at room 
temperature under vigorous stirring overnight. 
In order to examine the role of the acyl substituent in the photoprotection activity to be tested, 
an O-acetyl derivative of DHICA (DAICA) was also prepared by acetylation of the indole 
with acetic anhydride-pyridine overnight at room temperature. 
3.2.2 In vivo evaluation of efficacy of dioleoyl-MeDHICA as photoprotective agent 
UVB erythema  is considered as one of the most suitable models for studying in vivo skin 
damage after acute UV exposure.
190,191
 The extent of UVB-induced skin erythema may be 
monitored by means of reflectance spectrophotometry.  
The ability of dioleoyl-MeDHICA to reduce UVB-induced skin erythema was tested in 
healthy human volunteers. 10 healthy volunteers  (both sexes) of skin types II and III, with a 
mean age of 35 ± 13 years were selected. All the volunteers were informed in detail of the 
nature of the study and the procedures involved and gave their written consent. The subjects 
did not suffer from any ailment and were not on medication at the time of the study. 
Skin erythema was induced by UVB irradiation using an ultraviolet lamp (Skin-tester Kit, 
Cosmedico Medizintechnik GmbH, Scwennigen, Germany) which emitted in the range of 
UVB. The lamp is equipped with a six grid-containing square opening through which UVB-
light is emitted. The grids have different abilities to attenuate the UVB-light so that the 
percentages of UVB-light let through the opening are different. 
For each subject, the minimal erythema dose (MED) was preliminarily determined. MED is 
defined as the lowest time interval or dosage of UV light irradiation sufficient for producing a 
minimal, perceptible erythema (sunburn or redness caused by engorgement of capillaries) on 
unprotected skin within a few hours following exposure. 
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Three sites on the ventral surface of one forearm of each subject were chosen using a square 
template (1 cm
2
) and demarcated with permanent ink.  The creams were applied for three days 
on two of three sites, while a site was left untreated (control). On the fourth day the induced 
erythema was monitored by means of a reflectance visible spectrophotometer (X-rite 
mod.158- 964, Michigan, USA) having 45° illumination and 0° viewing angle. 
Spectrophotometers provide measures of the three coordinates of CIELAB:  L*, a* and b*.  
The lightness, L*, represents the darkest black at L* = 0, and the brightest white at L* = 100 
while a* and b* represents the position of the color between red/magenta and green (a* < 0 
indicates green while a* > 0 indicates magenta) and yellow and blue (b* < 0 indicates blue 
while a* > 0 indicates yellow) 
Preliminary results showed that oleoyl-MeDHICA afforded a significant protection to the skin 
against UVB-induced erythema, with significant differences with respect to the controls. On 
the other hand DAICA gave erythema values that were not significantly different with respect 
to the control. 
The higher lipophilicity of oleoyl-MeDHICA may explain the fact that it permeates through 
the stratum corneum better than DAICA, being more effective. 
3.2.3 Effects of carboxyl group substituents of indole precursors on eumelanin 
properties 
Understanding the relationships between structure, properties and function in melanin can 
elucidate its role in skin (photo) protection and UV-susceptibility.  
One of the main variation that can be observed and that strongly affects melanin properties, is 
the presence or the absence of the carboxyl group in the precursors.
192
 
The rearrangement of dopachrome  to DHI or DHICA
17
 constitutes an important branch in 
melanogenesis as carboxyl retention results in essential biological consequences such as 
antioxidant eumelanin properties that are enhanced in the case of DHICA melanin.
144
 
In vitro and at neutral pH, dopachrome spontaneously decomposes to give DHI and DHICA 
in a 70:1
193
 ratio but in the presence of dopachrome tautomerase (Dct, also called tyrosinase-
related protein-2, Tyrp2) or of metal cations, the formation of DHICA is favored.
35,194–196
 
Metal ions can also affect the course of pheomelanogenesis directing the synthesis towards 
generation of carboxylates moieties.
22
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Oxidative polymerization of DHI and DHICA produces eumelanin via a wide range of 
oligomers, mainly coupled through 2,2’-, 2,4’- and 2,7’-bonding in the case of DHI,197–199 
through  4,4’-, 4,7’- and 7,7’-bonding in the case of DHICA (Figure 43). This different 
reactivity is due to the electron-withdrawing carboxylic acid group that decreases the 
nucleofilicity of the pyrrole moiety and the reactivity of the 3- position.
197,199
   
 
Figure 43. DHI and DHICA dimers. 
While DHI oligomers exhibit a planar conformation with -stacked supramolecular 
aggregates, DHICA mainly polymerizes through biphenyl-type bond, adopting a non-planar 
conformation with a hindered rotation at the inter-ring bonds, giving reason to atropisomerism 
(Figure 44).
200,201
 Negative charges on the carboxylate groups reinforces this deviation from 
planarity, so while DHI oxidation produces planar species absorbing visible radiation, 
DHICA oligomers do not absorb above 400 nm because a significant interruption of -
electron delocalization.
154,160
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Figure 44. Predicted structures of DHI and DHICA dimers quinones. 
As already illustrated in paragraph 3.1 of this chapter dealing with the melanin chromophore, 
DHI melanin displays a monotonic profile,
155
 DHICA melanin shows an intense absorption at 
about 320 nm,
144
 suggesting the presence of both reduced monomer-like chromophoric 
components and quinonoid units. This is confirmed by the observation that the addition of 
NaBH4, a reducing agents, decreases the absorption in the visible range but does not affect the 
absorption at 320 nm due to the reducible quinonoid moiety. 
Comparing the spectra of DHI and DHICA melanin in the presence polyvinyl alcohol (PVA), 
that is able to prevent melanin precipitation,
135,153
 DHI but non DHICA melanin displays a 
broad band around 500 nm. Moreover, dilution in PVA containing buffer induce loss of 
visible absorption in DHICA melanin but not in DHI melanin (Figure 45). 
 
DHI dimer quinone
- p-stacked supramolecular 
aggregates
- Planar conformation
- Monotonic absorption
profile
DHICA dimer quinone
- Biphenyl-type bond
- Twisted conformation
- Atropisomerism
- Intense absorption at ca. 
320 nm
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Figure 45. DHICA and DHI melanin before and after 1:90 dilution in 1% PVA-containing 
buffer and intrinsic and extrinsic contributions to the chromophoric properties of DHI and 
DHICA melanin. 
These data suggested that DHI melanin chromophore derived from intrinsic effects due the -
delocalization while the DHICA chromophore is mainly determined by extrinsic contributes 
due to aggregation-dependent intermolecular perturbation of the -electron system.  
Both DHI and DHICA melanin are paramagnetic and display similar g-value in their EPR 
spectra but the DHICA melanin signal is significantly narrower than DHI one.
60,143,144,202
 
Moreover, power saturation curves show that free radical components in DHICA melanin are 
more homogenous, suggesting spatially confined within restricted segments of this polymer. 
DHI melanin seems to be characterized by a broader variety of free radical species, possibly 
generated within the delocalized -electron system of the DHI polymer. 
The decrease of B for DHICA melanin in the presence of 1% PVA suggests that the free 
radical population of DHICA melanin is markedly affected by intermolecular interactions. No 
differences were observed in the case of DHI melanin.
144
  
The decrease of DHICA content in melanin is associated with Dct inactivation that is also 
related to the increase of ROS levels following UVA exposure and the number of sunburn and 
apoptotic  cells in epidermis.
171
  
Antioxidant properties can be extended from monomer to melanin as also DHICA melanin is 
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a hydroxyl radical-scavenger in the Fenton reaction in a dose-dependent manner.
144
 DHI-
melanin, instead, acts as a pro-oxidant generating ROS, whose levels are decreased by 
DHICA melanin suggesting that the naturally occurring mix of DHI and DHICA unit in 
eumelanins is necessary to minimize ROS generation and protect skin cells from oxidative 
damage. 
Investigation of the excited-state dynamics of DHICA by ultrafast time-resolved fluorescence 
spectroscopy showed deactivation of the excited state that is mediated by inter-unit 
interactions within the oligomeric molecular scaffold.
120
 
DHICA melanin is a stronger hydroxyl radical–scavenger in vitro  with respect to DHI 
melanin, as confirmed in three different tests (Table 2), suggesting that Dct could regulate 
antioxidant properties.  
 
Table 2. Free radical scavenging properties of DHI and DHICA melanins.
144
 
 DHI melanin DHICA melanin 
DPPH (%) 29±1 100±4 
ABTS (%) 4±1 46±2 
NO (%) 26±1 64±3 
 
These antioxidant properties could be ascribed to the destabilizing effects of non-planar 
structures on electron delocalization and aggregation, imparting monomer-like behavior to the 
polymer. Weak aggregates would make free radicals more accessible than in the case of DHI 
melanin.  
All these data suggest that retention of carboxyl group play a key role in controlling pigment 
properties in eumelanins (Table 3).  
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Table 3. Comparison of the properties of eumelanins from 
carboxylated/non-carboxylated precursors. 
 DHI DHICA 
Monomer characteristics 
Reactive sites At least 4 Usually 2 
Oxidizability High Low 
Polymer properties 
Solubility 
(neutral pH) 
Nihil Very slight 
EPR signal intensity Strong Weak 
Visible absorption Intense Poor 
Photophysical 
properties 
Efficient 
excited state 
decay 
More efficient 
excited state decay 
Chemical properties 
Antioxidant More potent 
antioxidant 
 
Three features could account for differences in carboxylated or non carboxylated rich units in 
melanin: 
 Lower number of reactive sites available for polymerization and cross-linking 
 Lower oxidation potential 
 Negative charge 
This last characteristic can affect the structural properties of oligomers and their 
susceptibility to post-synthetic modifications. 
The role of carboxyl group is only partially elucidated in the case of pheomelanin while in 
the case of eumelanin it explains why an enzymatically-controlled pathway to produce a 
poor pigment precursor like DHICA instead of exploiting the spontaneous production of 
64 
 
DHI. Although caution must be exercised before extending conclusion from in vitro to in 
vivo situation, this latter point may be taken as an additional indirect argument against a 
merely pigmentation role of melanin in nature.  
 
3.2.4 The impact of esterification on 5,6-dihydroxyindole-2-carboxylic acid antioxidant 
activity and oxidative polymerization 
In order to understand the role of the carboxyl group as determinant of the chemical properties 
of the 5,6-dihydroxyindole system, DHICA and MeDHICA were compared. Their conversion 
to eumelanin chromophore and their antioxidant properties were investigated. 
Comparing the autoxidation behavior of DHICA and MeDHICA (50 M) in phosphate buffer 
(pH 8.5), a progressively decrease of the maximum of the indole at 320 nm was observed, 
replaced by the featureless broadband absorption typical of melanins. A similar course was 
observed in the case of both the indoles, but in the case of MeDHICA the autoxidation 
seemed to be slower and the indole was still partially visible at 48 h (Figure 46). 
 
Figure 46. Spectrophotometric course of the autoxidation mixture of DHICA or MeDHICA 
(50mM) in 0.1 M phosphate buffer, pH 8.5. 
Monitoring the course of the oxidation by reverse phase HPLC, a complete consumption of 
the monomer was observed at 72 h, while at 48 h the decay of the starting indole was about 
40%. The elutographic profile showed other more retained components the first eluted of 
which clearly predominant (Figure 47). A similar product pattern is obtained using potassium 
ferricyanide as oxidant, while the addition of metal ions like copper or cobalt to the 
autooxidation mixture, markedly accelerated the process, favoring the formation of the first 
eluted component, that was isolated by preparative HPLC from the oxidation mixture of the 
indole at 10 mM concentration in the presence of equimolar cobalt sulphate in 0.2 M HEPES 
buffer pH 7.5 over 15 min reaction time. 
0 min
24 min
48 h
72 h
96 h
7 d
MeDHICA
Phosphate buffer, pH 8.5
DHICA
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Figure 47. HPLC profile of the MeDHICA oxidation mixture with UV detection (280 nm). 
Blue trace: t = 0; red trace: t = 48h. 
 The product was identified as the 4,4’-biindolyl based on NMR analysis in comparison with 
data reported for DHICA dimers.203 Since also in the case of DHICA the autoxidation in the 
presence of metal ions gives 4,4’ dimer as the major oligomer, it can be concluded that the 
regioselectivity of the oxidative coupling observed for DHICA is not affected by 
derivatization of the carboxyl group.  
Melanin from MeDHICA (and from DHICA, for comparative analysis) were prepared using 
different oxidizing condition including autooxidation in phosphate buffer at pH 8.5 and 
chemical oxidants like ferricyanide, running the reaction until complete consumption of the 
indole as determined by HPLC analysis. The oxidation mixtures were acidified and the 
melanin pigment was separated by centrifugation. 
The solubility properties of MeDHICA and DHICA melanins prepared by autoxidation were 
assayed in different organic solvents selected among those with high miscibility in water, 
using a test concentration of 0.3 mg/mL and stirring the materials in the appropriate solvent 
for 15 min. 
min
4,4’-MeDHICA
dimer
MeDHICA
66 
 
Digital pictures of the solution/suspension in methanol or dimethyl sulfoxide (DMSO) chosen 
as representative solvents are shown in Figure 48. 
 
Figure 48. Digital pictures of 0.3 mg/mL DHICA (left) or MeDHICA (right) melanin prepared 
by autoxidation and stirred in methanol or DMSO for 15 minutes.  
In the case of DMSO, MeDHICA melanin was completely solubilized whereas DHICA 
melanin is not, while in methanol as well as in other solvents only a partial solubilization was 
obtained. Absorption spectra of the supernatants after discarding the solid materials and 
appropriate dilution showed absorption at around 330 nm in the case of MeDHICA melanin 
whose intensity correlated fairly well with the observed solubility in the solvents examined 
(Figure 49). 
 
Figure 49. Uv-vis spectra of DHICA and MeDHICA melanin in DMSO. 
Mass spectrometric analysis in the MALDI mode was run using 2,5-dihydroxybenzoic acid as 
the matrix and the melanin applied to the plate from a fine suspension in ethanol obtained by 
homogenization in a glass to glass potter.  
DMSOMethanol
DHICA melanin
MeDHICA melanin
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The spectrum of the MeDHICA melanin prepared by aerobic oxidation displays a well distinct 
pattern of signals corresponding to oligomers from the dimer to the octamer,   peaking at the 
trimer (Figure 50). Though it can not be ruled out that other high molecular weight 
components are not detected by this methodology, the spectrum provides evidence for a clean 
collection of intact oligomers as constituents of MeDHICA melanin. A similar though less 
defined spectrum was obtained for MeDHICA melanin prepared by ferricyanide oxidation 
(data not shown).   
 
Figure 50. MALDI spectrum of the MeDHICA melanin prepared by aerobic oxidation. 
EPR spectra of different MeDHICA melanins in comparison with one representative 
DHICA melanin were recorded. Almost identical g-values were exhibited by all melanins and 
signal amplitudes (ΔB) were comparable and relatively narrower (see Table 4) compared with 
those reported for DHI and other melanins.
144
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Table 4. EPR spectral parameters for MeDHICA and DHICA melanin prepared under 
different conditions. 
Sample B (G) spin/g g-factor 
MeDHICA 
autooxidation 
melanin 
4.4 ± 0.2 G 6.2 × 10
18
 2.0029 ± 0.0002 
MeDHICA 
ferricyanide melanin 
4.0 ± 0.2 G 2.4 × 10
18
 2.0029 ± 0.0002 
DHICA 
autooxidation 
melanin 
4.5 ± 0.2 G 8.2 × 10
17
 2.0029 ± 0.0002 
 
These data coupled with analysis of the power saturation curves (Figure 51) would confirm 
a similar free radical character of these melanins showing a good degree of homogeneity and 
low dispersion of the free radical components in full agreement with previous observations.  
 
 
 
Figure 51. Power saturation curves for MeDHICA and DHICA melanin prepared by 
autooxidation. 
MeDHICA autooxidation melanin
DHICA autooxidation melanin
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The spin density of MeDHICA melanins are of magnitude higher with respect to DHICA 
melanin, suggesting the presence of radical centers likely of semiquinone-type arising from 
disproportionation equilibria of localized quinone and indole units inside the pigment 
backbone, differently from what observed for DHI-melanin
144
 featuring extensively 
delocalized -electron systems with strong stacking interactions, in which the carbon 
centered component localized in the center of stacked units provides seemingly the 
predominant contribution.
143
   
Antioxidant properties of MeDHICA melanins (in comparison with respective monomers and 
4,4’ dimers) were assayed  by two chemical tests, namely the 2,2-diphenyl-1-picrylhydrazy 
(DPPH),
204
 an assay that measures the H-donor ability of a given species and the ferric 
reducing antioxidant power (FRAP),
205
 which measures the ability of the antioxidant to 
reduce a Fe
3+
-tripyridyltriazine complex to a dark blue Fe
2+
 complex with absorption 
maximum at 593 nm. 
In the case of DPPH (Figure 52) the EC50 i.e. the dose of the material at which a 50% DPPH 
reduction is observed, were determined. Very low and similar values were obtained for both 
monomers, whereas for the dimer the values were comparable and as low as 2.4 g/mL. This 
is in line with the high antioxidant potential of DHICA as reported in previous work by 
different assays which is substantially unaltered in the ester. 
In the case of melanins, a fine suspension was obtained by homogenization in a glass/glass 
potter. MeDHICA melanin obtained by autoxidation is a very effective antioxidant to an 
extent comparable or even higher with respect to DHICA melanin, but either pigments are 
less potent that their respective monomer or 4,4’-dimer.  
 
Figure 52. EC50 values from DPPH assay on DHICA and MeDHICA monomers, dimers, and 
melanin prepared by autooxidation. Data are expressed as mean ± SD of three independent 
experiments, each performed in duplicate. 
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In the case of FRAP (Figure 53), results were expressed as trolox equivalents and show 
comparable values in the case of the monomer and of the dimer, while MeDHICA melanin 
proved to be a stronger antioxidant than DHICA melanin. 
 
Figure 53. Ferric reducing power of DHICA and MeDHICA monomers, dimers, and melanin 
prepared by autooxidation, expressed as trolox equivalents. Data are expressed as mean ± SD 
of three independent experiments, each performed in duplicate. 
These results suggest that the role of the carboxyl group in melanogenesis from DHICA is 
more complex than simply blocking the 2-position of the indole ring, and can be modulated 
through the control of ionization of carboxylate anion. Based on the behavior of the ester, it is 
suggested that suppression of carboxylic acid ionization under the acidic conditions of 
melanosome interior enhances antioxidant properties while hindering dark melanin formation. 
However, data presented in this paragraph are only preliminary and still underway. 
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CHAPTER 4 
4.1 Mechanism of control of pigmentation 
Local excess of pigmentation (hypermelanosis) is one of the most common pigmentary 
disorder and can be the result of inflammatory responses or local abnormal melanocyte 
function.
2
 Several hyperpigmentary disorders are associated with the overproduction or 
accumulation of melanin, for example melasma or lentigo.
206
   
The aesthetically impact of such disorders have urged the search for non-toxic skin 
depigmenting agents.
207
 In the investigation of the mechanism of action of newly designed 
molecules or natural extracts the mechanisms of regulation of skin complexion were analyzed 
in detail. As a result several processes involved in the control of pigmentation were 
highlighted including inhibition of tyrosinase and related enzymes, regulation of melanocyte 
homeostasis, alteration of constitutive and facultative pigmentation, down-regulation of 
melanosome transfer to the keratinocytes, melanogenesis signalling proteins, tyrosinase 
expression and stability.
208
 
The key regulatory enzyme of melanogenesis is tyrosinase (EC 1.14.18.1), a copper 
containing complex whose structure is highly conserved among different species and widely 
distributed in the biosphere. This enzyme shows high homology with two tyrosinase-related 
protein, namely tyrosinase-related protein 1 (TRP1 or TYRP1) and tyrosinase-related protein 
2 (TYRP2 or Dct).
2
    
Tyrosinase can catalyzes two different reactions:
209
 
 hydroxylation of monophenol to o-diphenol (cresolasic or monophenolasic activity) 
 dehydrogenation of catechol to o-quinone (catecholasic or diphenolasic activity) 
 
 
Scheme 3. Reaction catalyzed by tyrosinase. 
In particular, tyrosine oxidation catalyzes the hydroxylation of the monophenol L-tyrosine to 
the o-diphenol L-3,4-dihydroxyphenylalanine (DOPA) and the oxidation of DOPA to the o-
quinone Dopaquinone. The binding site for L-tyrosine and L-DOPA is the same and the 
reactions involve an electrons exchange with copper atoms
210,211
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Oxidation rates depend on several factors, like tyrosinase concentration, oxygen availability, 
pH and temperature.  
Moreover, tyrosinase activity and stability are strictly connected to redox conditions, having 
four possible oxidation states (Figure 54).
212
 Inactive enzyme ([Cu(II)2], met-tyrosinase) is 
activated by reduction of its two Cu
2+
 to Cu
+
 giving the fully active form deoxytyrosinase, 
[Cu(I)2], that is able of binding dioxygen to form oxy-tyrosinase [Cu(II)2O2]. The most 
efficient electron donor is L-DOPA even if other reducing agent can activate the enzyme, 
acting on  the oxidation products of tyrosinase and inducing accumulation of DOPA.
2
 
Oxidation of catechols can lead to reductive elimination of one of the active-site copper ions 
and conversion to the inactive deact-tyrosinase [Cu(II)Cu(0)].
212
 
O-quinones generated by tyrosinase oxidation of catechols are of great importance in 
biochemistry, being able to form a wide range of pigments widespread in animals and plants. 
 
Figure 54. The four oxidation states of the active site of tyrosinase. 
Presently skin depigmenting and melanogenesis regulators acting through different 
mechanisms have been developed and are commercially available.
208
 
The first level that can be controlled to modulate the activity of tyrosinase and related 
enzymes is transcription. The microphthalmia-associated transcription factor (MITF) is the 
factor that regulates melanocyte cellular differentiation and the transcription of melanogenic 
enzymes (tyrosinase, TYRP1 and TYRP2) and melanosome structural proteins.
213–215
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The binding of α-melanocyte stimulating hormone (α-MSH) to the melanocortin 1 receptor 
(MC1R) stimulates the activation of adenyl cyclase and the consequent production of cAMP 
that in turn activates the protein kinase A (PKA) pathway to phosphorylate cAMP-responsive 
element binding protein (CREB) transcription factors. This one activates MITF-M promoter 
that induces melanogenesis. 
Lowering of the expression of tyrosinase mRNA acting on this pathway is one of the 
mechanism used by some efficient melanogenesis inhibitors, such as 2-aryl-1,3-
thiazolidines.
216–218
 An example is MHY384, an inhibitor  synthesized from 2,4-
dihydroxybenzaldehyde and cysteine,
218
 whose action has been attributed to its intervention in 
the NO-induced melanogenic pathway:
219
 UV-exposed keratinocytes produced NO that 
activates guanylate cyclase (GC), which produces cGMP, that in turn activates protein kinase 
G (PKG).
220,221
 According to a mechanism proposed, MHY384 would scavenge NO being 
reduced to nitroxyl (HNO) by H atom donation from the phenolic group of thiazolidine, 
decreasing cGMP levels and the phosphorylation of cAMP response element binding (CREB) 
protein via the PKG/cGMP signaling.
219
 As proposed in a commentary
222
 prepared on 
invitation by Experimental Dermatology, the species involved in the redox reaction could 
rather be NO2 (produced by NO under aerobic conditions)
223
 capable of generating a 
nitrophenol derivative by reaction  with the phenoxyl radical.
224,225
 Otherwise, the –SH group 
derived from the cleavage of the thiazolidine could react with the dopaquinone generated by 
the tyrosinase catalyzed oxidation of tyrosine. The hydrolysis of the thiol conjugated immine 
product would lead to the 2,4-dihydroxybenzaldehyde and cysteinyldopa (a pheomelanin 
precursors) (Figure 55). The opportunity of acting through such a variety of mechanisms may 
represent an advantage allowing to improve the efficacy of these inhibitors, reducing the 
duration of therapy and the risk of adverse effects. 
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Figure 55. Multiple mechanisms by which MHY384 and structurally related 2-aryl-1,3-
thiazolidines control of melanin pigmentation in vitro and in vivo. Bent arrows indicate the 
sites of intervention. Adapted from Napolitano et al. 2016.
222
 
One of the most common approach for control of pigmentation involves the use of tyrosinase 
inhibitors like phenols, hydroquinones, flavonoids, stilbenes and coumarins.
226
Actually, only 
a few tyrosinase inhibitors have practical application as several factors should be considered, 
such as cytotoxicity, solubility, cutaneous absorption, and stability.  
Moreover, further to the case of rhododendrol (RD),
227
 a skin whitening agent that has been 
reported to cause leukoderma, an increasing attention is paid to the toxicity of depigmenting 
agent in vitro and in vivo. Tyrosinase catalyzes the production of toxic metabolites of RD
228
 
whose toxicity in melanocytes is exerted by mediation of ROS. These species, identified as 
RD-quinone, which is quickly converted to RD-cyclic quinone through an intramolecular 
addition of the hydroxy group, irreversibly bind to  nucleophilic site of the enzyme causing 
melanocytes apoptosis.
229,230
 Tyrosinase phenolic inhibitors should therefore  be tested as 
substrates in order to ensure their safety. 
Many simple phenolic compounds have been demonstrated to show inhibitory effects on 
melanogenesis through inhibition of the enzymatic activity of tyrosinase. For example, 
hydroquinone has been extensively used in the treatment of melasma.
231
 However, because of 
its side effects, its use has important legal restrictions.  
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Dermatologic research has been encouraged to seek for new safe tyrosinase inhibitors for 
dermocosmetic applications to reduce skin hyperpigmentation. An increasing attention has 
been focused on the evaluation of the effect of structural modifications on the properties of 
phenolic systems from natural sources. 
An investigation of the electronic and hydrogen bonding effects of the ortho and para 
substitution of phenols with alkylthio groups showed that the chain-breaking antioxidant 
activity of these derivatives is enhanced by decreasing the bond dissociation enthalpy of the 
OH group and affecting the reaction rate with peroxyl radicals.
232
 
Among thioalkyl substituents, a particular attention was directed to dihydrolipoic acid 
(DHLA) a carboxylic acid featuring a pair of thiol groups.  
 
DHLA is the reduced form of lipoic acid (LA, also known as vitamin N) and together with its 
oxidized form fulfills two main functions:
233
 
 It is a cofactor of numerous enzymes involved in oxidative decarboxylation of 
pyruvate and other ketoacids, being continuously regenerated.
234,235
  
 The LA/DHLA system possesses one of the lowest standard biological redox 
potentials (E0 = -0.29 V), being able to reduce not only ROS but also the oxidized 
forms of other antioxidants. It is able of scavenging hydroxyl radical, hypochlorous 
acid and peroxynitrite, and chelating Fe
2+
 ions.
236 
Moreover, LA and DHLA are easily 
soluble both in fats and water, and can exert their functions both at membrane level 
and in aqueous phases of cytoplasm. 
Lipoic acid administration has been shown to be beneficial in the treatment of diabetes,
237
 
cataract formation,
238
 and in the prevention of neurodegenerative pathologies.
239–241 
Lipoyl-conjugates with L-DOPA and dopamine (DA)  were prepared and tested for their 
antioxidant and iron-chelating properties, as a premise to assess their potential in treating 
pathologies such as Parkinson's disease.
242
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The free sulfhydryl groups of DHLA can react with dopaquinone to form lipoyl DOPA 
conjugates
243
 and indeed lipoyl derivatives have been shown to affect melanin production by 
formation of DOPA conjugate products.
244
 
On this basis the research activity developed was aimed at the preparation of a conjugate of 
DHLA with caffeic acid, a hydroxycinnamate compound widely diffused at relatively 
elevated levels in various agricultural products as pears. 
 
Caffeic acid is involved in immunoregolation and in a variety of diseases, including allergic 
conditions and asthma. Moreover it is a strong and selective transcription inhibitor of matrix 
metalloproteinase, that are directly involved in human hepatic tumorigenesis and 
metastasis.
245
 
Caffeic acid linked to aminoacid residues such as the  caffeoyl-prolyl-hydroxamic acid (CA-
Pro-NHOH) proved an excellent tyrosinase inhibitor,
246
 while CA alone, that is known to be a 
substrate for tyrosinase like L-DOPA,
247
 was not. It is possible that this derivative has the 
appropriate structure for binding to the active site of tyrosinase due to its hydrophobicity. 
Actually, amino acids containing hydrophobic aliphatic group like Leu are known to play an 
important role in tyrosinase inhibition, and amino acids containing a hydrophobic aromatic 
ring like Phe can interact with tyrosinase being similar to tyrosine, the natural substrate of the 
enzyme.
248
 Also amidic derivatives of caffeic acid with serine ore lysine, in particular N-
Caffeoyl-O-acetylserine methyl ester showed strong tyrosinase inhibition activity.
249
  
4.2 Preparation of a conjugate of caffeic acid with dihydrolipoic acid 
The synthesis of the conjugate of  caffeic acid (CA) with dihydrolipoic acid (DHLA) was 
carried out adapting a procedure previously reported for hydroxytyrosol, using p-coumaric 
acid as the starting product.
30
 
A strategy was adopted that involved the generation of the o-quinone of caffeic acid from p -
coumaric acid, followed by in situ addition of DHLA. 
Regioselective hydroxylation of coumaric acid was achieved by reaction with 2-
iodoxybenzoic acid (IBX)
250
 affording to the o-quinone of caffeic acid. 
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The reaction mechanism,
251
 not fully elucidated, should involve the reaction of coumaric acid 
with the IBX with elimination of a molecule of water from the intermediate A, that rearranges 
to B via oxygenation of the ortho-position of the phenolic group and concomitant reduction of 
the iodine from I (V) to I (III). Tautomeration of B gives the intermediate C that breaks down 
into the o-quinone and 2-iodobenzoic acid, while iodine (III) is reduced to iodine (I) (Figure 
56). 
 
Figure 56. Proposed mechanism for the generation of  o-quinone of caffeic acid. 
IBX was prepared oxidizing 2-iodobenzoic acid with oxone® in water at 70° C, following a 
reported procedure.
250
 
DHLA was prepared by reduction of lipoic acid with sodium borohydride, according to a 
previously reported procedure.
252
  
Briefly, to an aqueous solution of a racemic mixture of LA (0.25 M) in 0.25 M NaHCO3, 
NaBH4 (1.0 M) at 0°C was added. After 2h the mixture was acidified to pH 1 and extracted 
with toluene (89%).  
Solid IBX (1.5 eq.) was added to a methanolic solution of p-coumaric acid (70 mM) at room 
78 
 
temperature. After 4 min, DHLA (4 eq.) was added drop by drop to promote the nucleophilic 
addition instead of redox exchange between the o-quinone and DHLA, giving as byproduct 
caffeic acid. 
 
In order to isolate the conjugate, the mixture was diluted with water, acidified until pH 1 and 
extracted with solvents at increasing polarity. A hexane/toluene (8:2, v/v) mixture allowed to 
remove 2-iodobenzoic acid, LA and DHLA, while chloroform extracted the lipoylcaffeic 
adduct isolated in 20% yield. It is possible to recover the more polar caffeic acid remained in 
solution by ethyl acetate extraction. 
The identity of the product was confirmed by 
1
H and 
13
C NMR (Figure 57) that allowed to 
elucidate the regiochemistry of the addition, as the spectrum displays two doublets at  6.86 
and 7.22 with a J of 8.4 Hz typical of an ortho relationship indicating that the conjugation as 
occurred at position 2 in line with what observed in previous studies for the reaction of thiols 
to hydroxycinnamate.
253,254
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Figure 57. 
1H and 13C resonances of 2-S-lipoylcaffeic acid.  
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4.3 Inhibition of mushroom tyrosinase activity by 2-S-lipoylcaffeic acid 
The tyrosinase inhibitory activity of 2-S-lipoylcaffeic acid was investigated using mushroom 
tyrosinase that is routinely used for assessment of the activity of potential tyrosinase 
inhibitors (Figure 58).
255–259
 
 
Figure 58. Simplified scheme of enzymatic reaction that is monitored in the mushroom 
tyrosinase assay. 
The compound was incubated in 50 mM phosphate buffer (pH 6.8) in the presence of 
mushroom tyrosinase (20 U/mL) at room temperature for ten minutes. Following incubation, 
L-DOPA was added (1mM final concentration) and the amount of dopachrome production in 
the reaction mixture was determined spectrophotometrically at 475 nm after further 10 
minutes (Figure 59). 
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Figure 59. Course of the oxidation of L-DOPA with mushroom tyrosinase in the presence of 
different concentrations of 2-S-lipoylcaffeic acid Data are expressed as mean of three 
independent experiments, each performed in duplicate (SD < 5%).  
 
Percent of inhibition was calculated as follow: 
 
% 𝒊𝒏𝒉𝒊𝒃𝒊𝒕𝒊𝒐𝒏 = (𝟏 −  
𝚫𝐀𝟒𝟕𝟓/𝐦𝐢𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐩𝐫𝐞𝐬𝐞𝐧𝐜𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫
𝚫𝐀𝟒𝟕𝟓/𝐦𝐢𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐚𝐛𝐬𝐞𝐧𝐜𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫
) x 100 
 
Figure 60 shows that the lipoyl conjugate of caffeic acid is able to induce a maximum 
inhibition of more than 80% at a concentration of 7 µM.   
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Figure 60. Percent of inhibition of mushroom tyrosinase activity versus 2-S-lipoylcaffeic acid 
concentration using L-DOPA as substrate. Data are expressed as mean ± SD of three 
independent experiments, each performed in duplicate.  
The strength of an inhibitor is usually expressed as the inhibitory IC50 value, which is the 
concentration of an inhibitor needed to inhibit half of the enzyme activity in the tested 
condition. IC50 value was determined by linear interpolation between two points limiting the 
range including 50% inhibition (Figure 61). This value was 3.22 ± 0.02 µM. 
 
Figure 61. Plot used for IC50 determination by linear interpolation using L-DOPA as 
substrate. 
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Since  the IC50 values for the tyrosinase inhibitors are usually incomparable due to the varied 
assay conditions, kojic acid (KA) that is thought  to inactivate tyrosinase by chelating copper 
atoms.
260
 is often used as a positive control.
261
 KA is a fungal metabolite currently applied as 
a cosmetic skin-lightening agent even if its use has been limited because of some side effects 
such as sensitization, contact dermatitis and erythema. IC50 for KA under the same conditions 
used for 2-S-lipoylcaffeic acid was 340 µM. 
Figure 62 shows oxidation mixtures of L-DOPA in the presence and in the absence of 10 µM 
2-S-lipoylcaffeic acid after 10 minutes: the inhibition effect on the formation of the melanic 
pigment was well apparent. At the same concentration, caffeic acid and KA did not induce 
any inhibition. 
 
Figure 62. L-DOPA oxidation mixtures in the absence (vial B) or in the presence of inhibitor 
(LC: 2-S-lipoylcaffeic acid; Caf: caffeic acid; Koj: kojic acid). 
The mechanism of inhibition of the lipoyl conjugate was then investigated. The bases of 
enzymatic kinetic rely on the theory by Michaelis and Menten, involving the following points: 
 The rate of a reaction depends both on the substrate and enzyme concentration. 
When the substrate has completely saturated the enzyme giving the complex 
enzyme-substrate, the rate reaches a maximum and an increase of the substrate 
concentration does not increase the rate of the reaction. 
 The enzyme (E) reacts with the substrate (S) to give the ES complex with a 
reversible reaction 
 
Where  
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k1 = Forward rate 
k-1 = Reverse rate  
ES releases final product P regenerating the original enzyme. The inverse 
reaction is neglected since its rate is minimum because the amount of the 
starting product is very low.  
 
The global process consists of two consecutive reactions: 
 
During the reaction the concentration of ES complex reaches a constant value (hypothesis of 
stationary state): this value determines the rate of formation of the final products. 
The rate of formation of the ES complex will be:  
Vformation = k1[E][S] 
While the rate of dissociation will be:  
Vdissociation = k-1[ES] + k2[ES] = (k-1 + k2) [ES] 
Under steady-state condition the rate of formation and the rate of dissociation of the 
ES complex will be the same. 
k1[E][S] = (k-1 + k2) [ES] 
Since [E] is the concentration of the free enzyme and [ES] is the concentration of the 
enzyme-substrate complex, from the enzyme conservation law we have that their 
sum will give the total concentration of the enzyme, E0: 
[E] + [ES] = [E]o 
So: 
[E] = [E]o – [ES] 
Combining with the previous expression:  
k1 ([E]o – [ES]) [S] = ( k-1 + k2) [ES] 
k1 [E]o[S] – k1 [ES][S] = ( k-1 + k2) [ES] 
Multiplying both the side of the equation by  -1: 
-k1 [E]o[S] + k1 [ES][S] = – (k-1 + k2) [ES] 
k1 [ES][S] + ( k-1 + k2) [ES]= k1 [E]o[S] 
Solving the equation for [ES], we get:  
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[ES] = k1 [E]o[S]/ (k1[S] + k-1 + k2) 
So the rate of formation of the product will be: 
V = k2[ES]= k2 k1[E]o[S]/ (k1[S] + k-1 + k2) 
Dividing by k1: 
V = k2[E]o[S]/ ((k-1 + k2)/k1 + [S]) 
The quantity k-1+ k2/k1  is indicated as KM (Michaelis-Menten constant), so it is 
possible to write the so called Michaelis-Menten equation:
262
  
V0 = k2[E]o[S]/(KM + [S]) 
This equation allows to calculate the rate of the reaction as a function of the concentration of 
the substrate [S] for a given concentration of the enzyme. The trend of the function is 
hyperbolic (Figure 63). 
 
Figure 63. “Saturation curve for an enzyme reaction showing the relation between the 
substrate concentration and reaction rate.” by Thomas Shafee. The image is licensed under a 
creative common attribution CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/) and it 
is available on Wikipedia. 
- At low substrate concentration, [S] << KM. Under these conditions the reaction rate 
increases proportionally to the increase of substrate concentration (first order kinetic).  
Because the enzyme is in excess with respect to S, its concentration can be considered 
constant. 
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- When the concentration of the substrate is high, [S] >>  KM, V asymptotically 
approaches its maximum rate (Vmax), indicating that all the enzyme is bound to 
substrate. The reaction becomes independent of [S] and further addition of substrate 
does not affect the rate of the reaction (zero-order kinetics). Vmax only depend on the 
total concentration of the enzyme (E0) and describe the maximal rate of decrease  of 
substrate's concentration or growth of the product concentration in a specified time 
unit. 
.                                          Vmax = k2[E]0 
The equation of Michaelis-Menten can be written as follows: 
V = Vmax [S]/( KM+ [S]) 
If we consider  the reaction rate being half of Vmax 
V = Vmax/2 
Substituting V with Vmax/2 in the  previous equation we have: 
Vmax/2 = Vmax [S]/ (KM+ [S]) 
 So: 
1 = 2 [S]/ (KM+ [S]) 
Multiplying both the sides of the equation by (KM+ [S]) we have:  
KM+ [S] = 2 [S] 
Or  
KM  = [S] 
KM constant represents the substrate's concentration for which the initial enzymatic 
conversion rate is equal to ½Vmax and depends not only on the enzyme and the 
substrate but also on reaction conditions such as pH and temperature.
263
 It is an 
inverse measure of the affinity of the substrate for the enzyme: small kM means high 
affinity as the rate will approach Vmax with a lower substrate concentration. 
KM is characteristic for each enzyme and indicates the affinity of the enzyme to its substrate: 
the lower is KM the lower is the S concentration that allows to have half of Vmax, showing that 
enzyme and substrate tend to react. An high value of KM indicates that an high concentration 
of S is needed to reach half of Vmax. 
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A useful tool for the analysis of the kinetic behavior during the oxidation of L-tyrosine or L-
DOPA is the Lineweaver–Burk double reciprocal plot, obtained from the reciprocal of the 
Michaelis-Menten kinetics equation. 
1/V = KM/(Vmax[S]) + 1/Vmax 
The data are displayed as a plot of 1/V versus 1/[S] giving a straight line whose slope is 
KM/Vmax and whose intersection with the X-axe is 1/Vmax (Figure 64). 
 
Figure 64. An example of Lineweaver–Burk plot by Pro bug catcher. The image is licensed 
under a creative common attribution CC BY 3.0 (https://creativecommons.org/licenses/by-
sa/3.0/) and it is available on Wikipedia. 
The kinetic of enzymatic reaction can be altered by the presence of inhibitor that are classified 
into three main groups:
260
  
 The competitive inhibitors bind to unoccupied enzymes' active sites 
competing with the substrate and altering the formation of ES complexes, but 
cannot bind to ES. The affinity of this substrate to the enzyme molecule 
decreases with a consequent increase of the KM, since an higher concentration 
of S is needed to reach half of Vmax that remains unchanged because the 
competition between substrate and inhibitor may be surpassed when the 
substrate's concentrations dramatically exceeds the concentration of the 
inhibitor (Figure 65). 
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Figure 65. Diagram showing competitive inhibition. 
 
 The non-competitive inhibitors have the same affinity to free enzyme (E) 
and to enzyme-substrate complex (ES), so they can  bind to the enzyme 
without blocking substrate's access to enzyme's active site but altering the 
enzyme structure. For this reason, catalytic properties of enzyme are modified 
and Vmax decreases but KM remains the same (Figure 66). 
 
Figure 66. Diagram showing non-competitive inhibition. 
 
 Mixed inhibitor binds to both E and ES partially blocking an access of 
substrate to enzyme's active site. The effect on kinetic constants depends on 
the affinity of E and ES to the inhibitor. It leads to an increase of KM value 
and a decrease of Vmax value (Figure 67). 
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Figure 67. Diagram showing mixed inhibition. 
 
Figure 68 shows the Lineweaver-Burk plots of the different kinds of inhibition. 
 
 
Figure 68. “Double reciprocal plots for competitive, uncompetitive, and noncompetitive 
(mixed) inhibitions.” by Bizz11. The image is licensed under a creative common attribution 
CC0 (https://creativecommons.org/publicdomain/zero/1.0/deed.en)and it is available on 
Wikipedia. 
The inhibition kinetics of the enzyme by the of  2-S-lipoylcaffeic acid was analyzed 
by the Lineweaver–Burk plots compared to data obtained in the absence of inhibitor 
(control). Experiments were carried out using the same protocol described above, 
except for varying concentrations of L-tyrosine or L-DOPA.  
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The plots for tyrosinase activity in the presence of increasing concentrations of L-
DOPA yield a family of straight lines with different slopes intersecting one another 
in the fourth quadrant (Figure 69).  
 
 
Figure 69. Lineweaver–Burk plots for inhibition of mushroom tyrosinase in presence of 2-S-
lipoylcaffeic acid. Data are expressed as mean ± SD of three independent experiments, each 
performed in duplicate. 
While the concentration of the 2-S-lipoylcaffeic acid increased, Vmax decreased and KM 
increased. These results suggest a mixed type of inhibition inhibitor. When L-DOPA was 
added as a substrate, increasing concentrations of the inhibitor increases the KM of tyrosinase, 
while it produced a decrease of Vmax, as observed in the family of lines with different slopes 
and  intercept on the X-axe. 
Figure 70 shows that in the presence of 2-S-lipoylcaffeic acid both the rate of the reaction and 
Vmax decrease. 
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Figure 70. Course of enzymatic kinetic of the tyrosinase induced oxidation of L-DOPA in the 
presence and in the absence of 2-S-lipoylcaffeic acid. Data are expressed as mean ± SD of 
three independent experiments, each performed in duplicate. 
 
The effect of the mushroom tyrosinase on the inhibitor was examined to verify if 2-S-
lipoylcaffeic acid was oxidized by the enzyme. The inhibitor (250 µM) was incubated in the 
presence of the enzyme under the same conditions of the spectrophotometric assay. HPLC 
analysis of the oxidation mixture after 10 minutes does not show any consumption of the 
inhibitor suggesting that it is not an alternative substrate of the enzyme. The same result was 
obtained in the presence of L-DOPA. 
The effect of preincubation of the enzyme was investigated performing the 
spectrophotometric assay by adding the inhibitor (3 µM final concentration) to the 50 mM 
phosphate buffer (pH 6.8) containing tyrosinase solution, after ten minutes. After further 10 
minutes absorbance was registered (475 nm) and the values obtained was comparable those 
obtained without preincubation. 
Another control experiment was run to rule out the possibility  that the abatement of 
absorbance at 475 nm was due to a redox exchange or addition to dopachrome. The 
experiment was performed as above but the inhibitor was added to the reaction mixture after 
10 minutes reaction between tyrosinase and L-DOPA. 
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The value of absorbance at 475 nm after 5 minutes did show not difference with respect to 
values registered before the addition of the inhibitor, excluding a possible reaction between 2-
S-lipoylcaffeic acid and dopachrome. 
In separate experiments the ability 2-S-lipoylcaffeic acid (100 µM final concentration) to 
inhibit the monophenolasic activity of mushroom tyrosinase was investigated, using L-
tyrosine instead of L-DOPA. 
Figure 71 shows the result when L-tyrosine is used as substrate. Also in this case, a strong 
inhibition activity was observed (>90%). 
 
Figure 71. Spectrophotometric course of tyrosinase induced oxidation of L-tyrosine in the 
presence and in the absence of 2-S-lipoylcaffeic acid (LC). Data are expressed as mean of 
three independent experiments, each performed in duplicate (SD < 5%).   
 
The assay was performed at different concentrations of inhibitor. Figure 72 shows 
percent of inhibition vs. concentration, pointing out that 50 µM 2-S-lipoylcaffeic acid 
is able to induce a maximum inhibition of ca. 90%. 
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Figure 72. Percent of inhibition of mushroom tyrosinase activity versus 2-S-lipoylcaffeic acid 
concentration using L-tyrosine as substrate. Data are expressed as mean ± SD of three 
independent experiments, each performed in duplicate.  
IC50 value was determined by linear interpolation between two points limiting the range 
including  50% inhibition (Figure 73). This value was 3.22 ± 0.02 µM. This values was 2.0 ± 
0.1 µM.   
 
Figure 73. Plot used for IC50 determination by linear interpolation using L-tyrosine as 
substrate. 
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In conclusion these experiments highlighted  the 2-S-lipoilcaffeic acid adduct as a potent non-
competitive inhibitor of tyrosinase either in the tyrosine or in the DOPA oxidation with values 
of IC50 inhibition concentrations far lower those of the reference inhibitor kojic acid.  
Further experiments on cell cultures will be essential to evaluate the actual toxicity of this 
compound on keratinocyte/melanocytes and to confirm the inhibitory activity. This will 
represent the premise to evaluate the potential of this compound as novel skin depigmenting 
agent.    
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CHAPTER 5 
Conclusions 
The results reported in this thesis provide important advances in the definition of the 
mechanism of toxicity of pheomelanic pigments in the absence of light, and the origin of the 
eumelanin broadband absorption spectrum. Following investigation of the properties of indole 
precursors with special reference to DHICA, a bioinspired photoprotective agent was 
synthesized and tested and the impact of esterification on 5,6-dihydroxyindole-2-carboxylic 
acid antioxidant activity and oxidative polymerization was studied. Moreover, a conjugate of 
caffeic acid with dihydrolipoic acid was prepared and its capacity of inhibiting mushroom 
tyrosinase activity was evaluated. 
The main outcomes of this thesis can be summarized as follows: 
 Red Hair Pheomelanin (RHP), and to a minor extent Black Hair Eumelanin (BHE), 
can exert a light-independent pro-inflammatory and pro-oxidant action in 
keratinocytes cultures, possibly being internalized by endocytosis.
264
 RHP would 
lower endogenous antioxidant levels  and produce ROS, thus accounting for a 
permanent abatement of the antioxidant defense. This chronic oxidative stress 
condition could favor a chronic pro-inflammatory status, underlying cause of 
melanoma development in red hair phenotypes.
105
 Without excluding the recognized 
role of UV radiation, these data confirm that UV-independent events play an important 
function in carcinogenic processes pointing out that new strategies of prevention, other 
than sunprotection, could be necessary, with particular attention to the most 
susceptible individuals.  
  
 
 
 
Results relative to this part of the project were reported in the following publication: 
 “Light-indipendent pro-inflammatory and pro-oxidant effects of 
purified human hair melanins on keratinocyte cell cultures.” (2016)  S. 
Lembo , R. Di Caprio, R. Micillo, L. Panzella, A. Balato, A. Napolitano, G. 
Monfrecola Exp. Dermatol. 16, DOI:10.1111/exd.13122. 
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 Both eumelanin and pheomelanin can play a “catalytic” role promoting the shuttling 
of electrons between oxidants and reductants. Indeed melanin can be reduced 
accepting electrons from biological relevant antioxidant such as NAD(P)H and/or 
GSH and can be oxidized donating electrons to biological oxidant, e.g. O2, generating 
ROS. In particular the reverse engineering experiments showed that pheomelanin has 
a higher oxidative potential compared to eumelanin and could disrupt cellular redox 
balances through a redox-buffering mechanism. The pro-oxidant properties of 
polycysteinyldopamine (pCDA), a red hair-inspired polydopamine-like polymer able 
to deplete GSH and NADH levels, further confirm the ability of this pigment to 
mediate electron exchange.  
 
 
 
 Experimental and computational data presented in this thesis represent a broad 
comparative investigation on the formation and evolution of eumelanin chromophores, 
a process involving three phases 
PHASE I: the rapid melanochrome generation is due to the contributes of the intrinsic 
chromophores of the oligomers in a stable oxidation state. The presence of the 2-
carboxyl group
192
 influences the absorption properties of DHICA melanin decreasing 
the generation of melanochrome. Comparing spectrophotometric oxidation courses of 
monomers and dimers, it was observed that the spectra of 4,4’-dimer of DHICA are 
almost superimposable to those of the corresponding monomer, while in the case of 
DHI, monomer and dimers displayed marked differences, especially in this first phase. 
PHASE II: the band broadening process is due to an intermolecular 
reorganization/equilibration of redox states. Acidification but not alkalization affects  
Results relative to this part of the project were reported in the following 
publications: 
 “Reverse Engineering Applied to Red Human Hair Pheomelanin 
Reveals Redox-Buffering as a Pro-Oxidant Mechanism.” (2015)  E. Kim, 
L. Panzella, R. Micillo, W.E. Bentley, A. Napolitano, G.F. Payne Sci Rep. 
5: DOI: 10.1038/srep18447. 
 “Tailoring melanins for bioelectronics: polycysteinyldopamine as 
ion conducting redox-responsive polydopamine variant for pro-oxidant 
thin films.”  (2015) N. F. Della Vecchia, R. Marega, M. Ambrico, M. 
Iacomino, R. Micillo, A. Napolitano, D. Bonifazi, M. d’Ischia J. Mater. 
Chem. C. 3, 6525–6531. 
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the chromophores, suggesting that the chromophoric species could be present in an 
ionized quinonoid form at neutral pH. Both melanochromes and eumelanin final 
chromophores can be partially reduced with sodium dithionite but are not affected by 
further addition of oxidizing agents. The  redox mixing would explain the resistance to 
oxidation and, at least in part, to reduction. Mutual perturbation would lead to the 
broadening of the absorption band, ascribable to extrinsic contributions (as suggested 
by the inhibitory effect of PVA). Computational data showed that the formation of a 
HQ/Q dimer is able to generate a large band in the visible region due to stacking 
processes between dimers pairs. These process are favored in DHI rather than in 
DHICA because of the twisted conformation of the carboxy-derivative.  
PHASE III: the black color is a consequence a stronger -electron stabilization in the 
solid state.  
 
Overall, the data concur to point out the importance of intermolecular interaction 
between catechol and quinone moieties or related extended quinone moieties as one of 
the major determinant of the band broadening and the black color of eumelanin. The 
final visible chromophores are determined by both intrinsic and extrinsic contributions 
in the case of DHI melanin, while in the case of DHICA melanin the extrinsic 
contribute is predominant.  
These results constitute  a solid background for the design of eumelanin-inspired 
functional materials tailored to dermocosmetic applications,
147
 such as hair dyes or 
photoprotective agents. 
 
 
 
 
 
 
Results and concepts relative to this part of the project were reported in the 
following publication: 
 “Eumelanin broadband absorption develops from aggregation-modulated 
chromophore interactions under structural and redox control.” (2017) R. 
Micillo, L. Panzella, M. Iacomino, G. Prampolini, I. Cacelli, A. Ferretti, O. 
Crescenzi, K. Koike, A. Napolitano, M. d’Ischia, Sci Rep. DOI: 
10.1038/srep41532. 
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 Oleoyl-MeDHICA, afforded a significant protection to the skin against the UVB-
induced erythema. Further experiments will be essential to evaluate the mechanism of 
action of this DHICA derivative and investigate its antioxidant properties. Preliminary 
data presented in this thesis suggest its potential use as topical photoprotective agents. 
 
 
 
 The impact of carboxyl group esterification on DHICA, structural properties and 
antioxidant activity were evaluated pointing out that combining the antioxidant 
properties of DHICA with the more favorable solubility properties in alcoholic or 
other common organic solvents of its methyl ester could be a good strategy to exploit 
this material in a variety of applications including dermocosmetic formulations.265 
 
 
 
 Mushroom tyrosinase inhibition assays and definition of enzyme kinetics of 2-S-
lipoilcaffeic acid proved that this compound is a potent mixed inhibitor of the 
enzyme either using tyrosine or dopa as substrate, with values of the IC50 inhibition 
concentrations far lower those of the reference inhibitor kojic acid (2.0 µM  and 
3.22 µM vs. 340 µM in the case of kojic acid). Further experiments will be essential 
Concepts relative to this part of the project were reported in the following publications: 
 “A new light on the dark DNA damages.” (2017) R. Micillo, S. Lembo, G. 
Monfrecola, SKINmed Journal, 15: 409-411. 
 “A reappraisal of the biological functions of melanins and melanogens: The role 
of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) in skin (photo)protection.” 
(2014).  R. Micillo, L. Panzella, G. Fabbrocini, F. Ayala, G. Monfrecola  
Journal of Plastic Dermatology, 101: 252-255. 
Results and concepts relative to this part of the project were reported in the following 
publications: 
 "“Fifty Shades” of Black and Red or How Carboxyl Groups Fine Tune 
Eumelanin and Pheomelanin Properties.” (2016) R. Micillo, L. Panzella, K. 
Koike, G. Monfrecola, A. Napolitano, M. d’Ischia Int. J. Mol. Sci. 17, 746. 
 “Assessing the impact of carboxyl group esterification on the antioxidant 
activity, structural properties and stability  of 5,6-dihydroxyindole-2-carboxylic 
acid melanins.” R. Micillo, L. Panzella, M. Iacomino, O. Crescenzi, K. Koike, 
G. Monfrecola, A. Napolitano, M. d’Ischia (submitted). 
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to evaluate the cytotoxicity of this compound on keratinocyte/melanocytes and to 
confirm the inhibitory activity in vitro but preliminary results indicate a good 
potential of the compound for application as skin depigmenting agent. 
 
 
 
Some of the results and the concepts relative to this PhD thesis were presented to the 
following international meetings: 
- 19th European Society for Pigment Cell Research Meetings (Edinburgh, 2015)  
“Why are eumelanins black? A bottom-up approach to structure-absorption-color 
relationships.” R. Micillo, L. Panzella , O. Crescenzi , K. Koike , G. Monfrecola , M. 
d’Ischia , A. Napolitano. Poster awarded with the ESPCR Travel award. 
- 20th European Society for Pigment Cell Research Meetings (Milan, 2016)  
“The eumelanin carboxyl conundrum: unexpected impact of esterification on 5,6-
dihydroxyindole-2-carboxlic acid antioxidant activity and oxidative polymerization.” 
R. Micillo, L. Panzella, M. Iacomino, O. Crescenzi, K. Koike, G. Monfrecola, A. 
Napolitano, M. d’Ischia.  
 
 
 
 
 
 
 
Results and concepts relative to this part of the project were reported in the following 
publication: 
 “Melanin pigmentation control by 1,3-thiazolidines: does NO scavenging play a 
critical role?” (2016)  Napolitano, R. Micillo, G. Monfrecola Exp Dermatol. 25: 
596-597. 
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CHAPTER 6 
6.1 Pheomelanin pigments: (photo)toxicity and pro-oxidant properties 
6.1.1 Materials 
Hydrogen peroxide (30% v/v), threo-1,4-dimercapto-2,3-butandiol (d,l-dithiothreitol), sodium 
metabisulfite, proteinase K from Tritirachium album (EC 3.4.21.64),  
polyethylene(10)isooctylphenyl ether (Triton X-100), L-glutathione (GSH), L-Glutathione 
oxidized (GSSG),  nicotinamide adenine dinucleotide phosphate reduced form (NADPH), 
nicotinamide adenine dinucleotide reduced form (NADH), ethylenediaminetetraacetic acid 
disodium (EDTA-Na2),  3,4-Dihydroxy-L-phenylalanine (L-DOPA), dopamine hydrochloride, 
horseradish peroxidase (HRP; donor: H2O2 oxidoreductase, EC 1.11.1.7), sodium tert-
butoxide, thiobarbituric acid, trichloroacetic acid were commercially available and were used 
as obtained 
5-S-cysteinyldopa (5SCD),
110
 and 5-S-cysteinyldopamine (CDA)
266
 were prepared as 
reported. All solvents were HPLC grade. Bidistilled deionized water was used throughout the 
study. CDA thin film prepared by Dr. M. Iacomino (University of Naples) allowing the 
polymer (10 mM) to autoxidize in bicarbonate buffer (50 mM, pH 8.5) in the presence of 
quartz and glass cuttings.   
Biological samples. Red, black and white hair locks were donated from healthy volunteers. 
Informed consent was obtained from all subjects. Only hair samples that had not received 
dyeing or other chemical treatments were included in the present study. In particular, hair was 
collected from the nuchal region, as the proximal end was considered the less light exposed 
and selected for melanin extraction. 
6.1.2 Methods 
HPLC analyses were performed on a Agilent 1100 binary pump instrument equipped with and 
a SPD-10AV VP UV-visible detector and electrochemical detector (ESA Coulochem2) using 
a Synergi Hydro-RP 80A column (250 x 4.60 mm 4 m).  
For NADPH analysis, UV detection was used (wavelength set at 340 nm), with 0.2 M 
phosphate buffer (pH 6.0) /methanol 86:14 v/v as the eluent, at a flow rate of 0.7 mL/min. 
For GSH analysis the EC detector was set at +500 mV vs. an Hg/Hg2Cl2 reference electrode. 
Phosphate buffer 0.01 M (pH 3.0) containing methanol 98:2 (v/v) was used as the eluent, at a 
flow rate of 0.7 mL/min 
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For thiazole-2,4,5-tricarboxylic acid (TTCA) and pyrrole-2,3,5-tricarboxylic acid (PTCA) 
analyses, 1% formic acid (pH altered to 2.8 with sodium hydroxide)/methanol 97:3 (v/v) as 
the eluent, at a flow rate of 0.7 mL/min. Detection wavelength was set at 254 or 280 nm. 
UV spectra were recorded on a Jasco V-730 Spectrophotometer.   
6.1.3 Isolation of hair melanin
32,90
  
Pigment purification from red and black hair was carried out according to the following 
procedure.
84
 Briefly, hairs (5.0 g) were washed with acetone/dichloromethane/diethyl ether 
(2:1:1), to remove sebum, and left to air dry overnight. Subsequently they were cut into short 
segments approximately 2 mm long and submerged with 0.1 M phosphate buffer (pH 7.4). 
The suspension obtained was homogenized with a glass/glass potter and d,l-dithiothreitol (625 
mg) was added under a stream of argon; thereafter, the reaction mixture underwent vigorous 
stirring at 37°C for 18h. Proteinase K (40 mg) and d,l-dithiothreitol (600 mg) were added 
under an argon atmosphere and the mixture was stirred at 37°C for 18 h and centrifuged for 
20 min (3000 rpm, 4°C). The precipitate was washed with 1% acetic acid (3) and the 
supernatant was acidified to pH 3 with 4M. HCl, all stored at 4°C overnight and then 
centrifuged for 20 min (3000 rpm, 4°C). The new precipitate was washed with 1% acetic acid 
(3) again, and the combined precipitates were suspended in 0.1 M phosphate buffer (pH 7.4) 
and treated with d,l-dithiothreitol (600 mg) and proteinase K (40 mg). After 18h the mixture 
was treated as above, and the combined precipitates were subjected to 3 further digestions: 
protease K (24 mg) and d,l-dithiothreitol (360 mg), protease K (2 mg) and d,l-dithiothreitol 
(8.4 mg), protease K (3mg) and d,l-dithiothreitol (12.6 mg). Finally, a pellet was generated, 
suspended in deaerated phosphate buffer (20 mL), and treated with Triton X-100 (500 µL). 
The suspension was allowed to stir for 4h at 37°C and then centrifuged. The pellet obtained 
was washed three times with 1% acetic acid and once with nanopure water (12000 rpm, for 20 
min at 4°C). The supernatant was treated as above, acidified to pH 3 with 4M HCl, all stored 
at 4°C overnight and then centrifuged for 20 min (3000 rpm, 4°C). The combined precipitates 
were subjected to another digestion step with protease K (83 mg) and d,l-dithiothreitol (12.6 
mg). The final pigment pellet collected by centrifugation was washed and lyophilized. The 
overall purification procedure afforded 157 mg of pigment from black hairs, 124 mg from red 
and 65 mg from white ones. 
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6.1.4 Preparation of synthetic melanins  
Synthetic melanins were prepared by enzymatic oxidation of dihydroxyphenylalanine 
(DOPA),
88
 5-S-cysteinyldopa
75
  and cysteinyldopamine
267
 following previously reported 
procedures.  
6.1.5 Oxidative degradation 
Finely minced hair (10 mg) or purified hair melanins (5 mg) were suspended in 1 M NaOH 
(1mL) and treated with 30% H2O2 (50 µL, final concentration 1.5%) at room temperature and 
under vigorous stirring for 24h. The mixture was treated with 5% Na2S2O5 (200 µL), taken to 
pH4 with 4 M HCl, filtered through nylon membranes (13 mm, 0. 45 µm) and analyzed by 
HPLC.
90
 Melanin content of RHP and BHE was estimated by comparison of the yields of 
TTCA and PTCA, respectively, with those of reference synthetic pigment from 5- S-
cysteinyldopa for pheomelanin
268
 and 5,6-dihydroxyindole-2-carboxylic acid (DHICA) for 
eumelanin.
269
  A value of 2.8% (w/w) for RHP and 2.6% (w/w) for BHE was obtained. 
6.1.6 EDTA treatment 
Integrative experiments with the 3 compounds (RHP*, BEH*, WHP*) previously washed 
with EDTA, a strong chelating agent, have been performed to ensure removal of drugs or 
other substances possibly derived from environmental contamination. Purified RHP or BHE 
(3 mg) were suspended in 40 mM EDTA-Na2 solution (pH 5.8, 3 mL) and allowed to stir at 
room temperature overnight. Samples were centrifuged a 5000 rpm for 15 min at 20°C and 
the precipitates were washed six times with ultrapure water and lyophilized.
270
  
6.1.7 Determination of cellular antioxidants (GSH and NADPH)  
HaCat cells were suspended in 600 l PBS and sonicated (Sonicator bath Seneco Science, 
Milan, Italy) with 3 short burst of 30 sec followed by intervals of 30 sec to allow cooling. Cell 
debris was removed by centrifugation at 4°C for 30 min at 7500 rpm, and the lysates were 
analyzed by HPLC. 
6.1.8 Determination of  cellular thiobarbituric acid reactive substances (TBARS)  
Determination of thiobarbituric acid reactive substances (TBARS) was performed 
spectrophotometrically by an adapted procedure.
271,272
 In brief, 300 µL of lysate was treated 
with 10% trichloroacetic acid (0.5 mL), the mixture was heated at 95 °C for 15 min with 
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stirring and then allowed to cool and centrifuged at 3000 rpm at 4 °C for 15 min. The 
supernatant was added to a 0.67% solution of thiobarbituric acid and taken at 95 °C for 15 
min. After cooling the absorbance of the solution at 532 nm was measured and TBARS 
quantitated using a molar extinction coefficient of 1.56 *10
5
 M
-1
cm
-1
.  
6.1.9 GSH and NADH oxidation 
A 150 M solution of GSH or a 300 M solution of NADH  in 0.1 M phosphate buffer (pH 
7.4) was allowed to stand at room temperature under vigorous stirring in the presence and in 
the absence of pCDA (1 mg) or  pCDA thin film. Aliquots of the reaction mixtures were 
periodically withdrawn and analyzed by HPLC with UV and electrochemical detector. 
6.2 Eumelanin pigments: (photo)protective and antioxidant properties 
 6.2.1 Material 
3,4-Dihydroxy-L-phenylalanine (L-DOPA), dopamine hydrochloride, hydrogen peroxide 
(30% v⁄v), potassium ferricyanide, sodium periodate, nickel sulfate eptahydrate, copper 
acetate, zinc sulfate heptahydrate, cobalt sulfate, ferric chloride, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), ceric ammonium nitrate (CAN), sodium dithionite, 
sodium borohydride, horseradish peroxidase (HRP; donor: H2O2 oxidoreductase, EC 1.11.1.7) 
and sodium tert-butoxide, oleoyl chloride, triethylamin (TEA), anhydrous 
tetrahydrofuran (THF) 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,4,6-tris(2-pyridyl)-s-triazine, 
and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (trolox) were purchased from 
Sigma-Aldrich. All solvents were HPLC grade. Bidistilled deionized water was used 
throughout the study. 
The ability of dioleoyl-MeDHICA to reduce UVB-induced skin erythema was tested  in 
healthy human volunteers. 10 healthy volunteers (both sexes) of skin types II and III, with a 
mean age of 35 ± 13 years were selected. All the volunteers were informed in detail of the 
nature of the study and the procedures involved and gave their written consent. The subjects 
did not suffer from any ailment and were not on medication at the time of the study. 
6.2.2 Methods 
HPLC analyses were performed on a Agilent 1100 binary pump instrument equipped with and 
a SPD-10AV VP UV-visible detector  using an octadecylsilane-coated column, 250 mm x 4.6 
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mm, 5 m particle size (Phenomenex Sphereclone ODS) at 0.7 mL/min. Detection 
wavelength was set at 280 nm.  
Analysis of oxidation mixtures of melanin precursors was performed using 1% formic acid: 
methanol 60:40 v/v as eluant in the case of MeDHICA  and the following gradient in the case 
of DHICA: 1.5% formic acid (eluant a)/ methanol (eluant b) from 5 to 90% b, 0-45 min.  
Preparative HPLC was carried out on an instrument coupled with a UV detector set at 280 nm 
using an Econosil C18 (10 m, 22 x 250 mm), at 15 mL/min, and 1.5% formic acid: methanol 
85:15 as the eluent in the case of DHICA and 1% formic acid: methanol 60:40 v/v in the case 
of MeDHICA. 
UV spectra were recorded on a Jasco V-730 Spectrophotometer.  
EPR measurements were performed using an X-band (9 GHz) Bruker Elexys E-500 
spectrometer (Bruker, Rheinstetten, Germany), equipped with a super-high sensitivity probe 
head. 
Samples were transferred to flame-sealed glass capillaries which, in turn, were coaxially 
inserted in a standard 4 mm quartz sample tube. Measurements were performed at room 
temperature. The instrumental settings were as follows: sweep width, 100 G; resolution, 1024 
points; modulation frequency, 100.00 kHz; modulation amplitude, 2.0 G. The amplitude of 
the field modulation was preventively checked to be low enough to avoid detectable signal 
overmodulation. Preliminarily, EPR spectra were measured with a microwave power of ~0.5 
mW to avoid microwave saturation of resonance absorption curve. Several scans, typically 16, 
were accumulated to improve the signal-to-noise ratio. Successively, for power saturation 
experiments, the microwave power was gradually incremented from 0.02 to 160 mW. The g 
value and the spin density were evaluated by means of an internal standard, Mn
2+
-doped 
MgO, prepared by a synthesis protocol reported in literature.
273
 
Skin erythema was induced by UVB irradiation using an ultraviolet lamp (Skin-tester Kit, 
Cosmedico Medizintechnik GmbH, Scwennigen, Germany) which emitted in the range of 
UVB. The lamp is equipped with a six grid-containing square opening through which UVB-
light is emitted. The grids have different abilities to attenuate the UVB-light so that the 
powers of the light let through the opening are different. (98.3, 122, 153, 192, 240, 300 
mJ/m
2
). Staff and participant wore UV protective glasses. 
104 
 
The induction of erythema was monitored by means of a reflectance visible 
spectrophotometer (X-rite mod.158- 964, Michigan USA having) 45° illumination and 0° 
viewing angle. 
MALDI analysis mode was run on a AB Sciex TOF/TOF 5800 instrument using 2,5-
dihydroxybenzoic acid as the matrix and the melanin applied to the plate from a fine 
suspension in ethanol obtained by homogenization in a glass to glass potter. Spectrum 
represents the sum of 15,000 laser pulses from randomly chosen spots per sample position. 
Raw data are analyzed using the computer software provided by the manufacturers and are 
reported as monoisotopic masses. 
 6.2.3 Preparation of 5,6-dihydroxyindole monomers 
5,6-dihydroxyindole (DHI),
85
 5,6-dihydroxyindole-2-carboxylic acid (DHICA)
85
 and 5,6-
dihydroxy-N-methylindole (N-MeDHI) were prepared as described.
199
  
MeDHICA was prepared starting from DOPA methylester prepared by reacting DOPA (2.0 g) 
in methanol (20 mL) with 96% sulfuric acid (2 mL) under reflux. After 24 h the mixture was 
allowed to cool and sodium bicarbonate was added to neutrality. The solution thus obtained 
was reacted in water with potassium ferricyanide under the same conditions used for 
preparation of DHI
85
  and after 15 min extracted with ethyl acetate to give pure Me-DHICA 
(1.3 g, 61% yield).  
 6.2.4 Preparation of 5,6-dihydroxyindole dimers 
2,2’-biindolyl,274 2,4’-biindolyl and 2,7’-biindolyl from DHI were prepared as previously 
described with slight modifications. Briefly, a solution of DHI (300 mg, 2.0 mmol) in 0.05 M 
phosphate buffer (pH 6.8) (120 mL) was treated with horseradish peroxidase (36 U/mL) and 
H2O2 (266 μL of a 30% solution, 2.3 mmol). After 25 s, the oxidation reaction was stopped by 
addition of a solution of sodium dithionite and rapidly extracted with ethyl acetate. After 
acetylation of the residue obtained following evaporation of the combined organic layers with 
acetic anhydride-pyridine overnight at room temperature the mixture was fractionated by 
column chromatography (gradient elution, CHCl3−ethyl acetate from 9:1 to 6:4) to afford the 
2,7’-biindolyl (45 mg, 10% yield, >95% pure) and the 2,4’-biindolyl (53 mg, 11%, >95% 
pure) as acetylated derivative. For isolation of the 2,2’-biindolyl as the O-acetyl derivative (30 
mg, 12% yield) DHI (150 mg, 1.0 mmol) was oxidized in air in 0.05 M HEPES buffer (pH 
7.5) in the presence of NiSO4·7H2O (560 mg, 2.0 mmol). After acetylation treatment of the 
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ethyl acetate extracts the residue was taken up in acetone and the product was recovered by 
filtration as white prisms.  
4,4’-Biindolyl from DHICA was prepared as previously described29 with modifications. A 
solution of DHICA (100 mg, 0.51 mmol) in 0.1 M HEPES buffer (pH 7.5) (495 mL) was 
treated with copper acetate (1 molar equivalent) and the reaction mixture was taken under 
vigorous stirring. After 10 min, the oxidation reaction was stopped by addition of sodium 
dithionite, acidified to pH 2 and rapidly extracted with ethyl acetate. The residue obtained 
following evaporation of the combined organic layers was fractionated by preparative HPLC. 
(16 mg, 16% yield, >90% pure).  
4,4’-Biindolyl from Me-DHICA was prepared as previously described194 with modifications. 
A solution of Me-DHICA (110 mg, 0.51 mmol) in 0.2 M HEPES buffer (pH 7.5) (33 mL) 
was treated with cobalt sulfate (1 molar equivalent) and the reaction mixture was taken under 
vigorous stirring. After 20 min, the oxidation reaction was stopped by addition of sodium 
dithionite, acidified to pH 2 and rapidly extracted with ethyl acetate. The mixture was 
fractionated by preparative HPLC. (18 mg, 12% yield, >90% pure). 
  6.2.5 Oxidation of 5,6-dihydroxyindole monomers and dimers  
15 L of a 10 mM solution of the appropriate indole monomer or 4,4’DHICA-dimer were 
followed by 2 molar equivalents of potassium ferricyanide (30L of a 10 mM solution in 
water). In the case of DOPA and DA the reaction was carried out with 6 molar equivalent of 
ferricyanide. The reaction mixtures were taken under vigorous stirring and periodically 
analyzed by UV-vis spectrophotometry. Spectra were registered at 5 min, 2 h and 24 h. After 
5 min in air, reaction mixtures were degassed and kept under stirring in an argon atmosphere. 
In other experiments the reaction was performed: 
i) in the presence of sodium periodate (1 molar eq.) 
ii) in the presence of CAN (2 molar eq.) in 0.1 M phosphate buffer (pH 3.0). 
iii) adding sodium dithionite or sodium borohydride after the addition of potassium 
ferricyanide (2 or 40 molar equivalents). 
iv) in the presence of ferric chloride or zinc sulfate or copper acetate (1 molar eq.) in 0.2 M 
HEPES buffer  
When required, oxidation mixtures were filtered through a 0.45 micron nylon membrane. 
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Substrate consumption was determined by HPLC analyses under the conditions described 
above.  
When required the reaction was carried in 0.1 M phosphate buffer (pH 7.0) containing 1% 
poly(vinyl alcohol) (PVA) to prevent  polymer precipitation. 
In the case of acetylated dimers the following protocol was followed: 5 mL of a 3.6 mM 
solution of the acetylated dimer in methanol were treated under an argon atmosphere with 
sodium tert-butoxide (8 molar equivalents) and after 5 min the pH of the solution was taken to 
2 by addition of 4 M HCl. 42 L of the resulting mixture was added to 3 mL of 0.1 M 
phosphate buffer (pH 7.0) to reach a final concentration of 50 M followed by 2 molar 
equivalents of potassium ferricyanide.  
6.2.6 Preparation of dioleoyl-MeDHICA 
Oleoyl-MeDHICA was prepared adapting a procedure by Mainini et al. 2013.
189
  
The identity of the product was secured by and LC-MS  and 
1
H- and 
13
C NMR. 
  6.2.7 Preparation of DAICA 
600 mg of DHICA were acetylated with 6 mL of acetic anhydride and 120 l of pyridine at 
room temperature overnight. After acetylation the product was suspended in 30 mL of a 
methanol/water solution (1:1) under reflux. After 4 h the solid product was filtered under 
vacuum and was left to dry at room temperature overnight (413 mg, 43% yield).   
   6.2.8 Evaluation of dioleoyl-MeDHICA photoprotective properties 
For each subject, the minimal erythema dose (MED) was preliminarily determined. MED is 
defined as the lowest time interval or dosage of UV light irradiation sufficient for producing a 
minimal, perceptible erythema (sunburn or redness caused by engorgement of capillaries) on 
unprotected skin within a few hours following exposure. 
After 24 h, the exposed areas of skin were examined. Red or pink skin indicates erythema or 
burning. Erythematous skin exposed to the shortest duration of UV is defined as the minimal 
erythema dose or MED. 
Three sites on the ventral surface of one forearm of each subject were chosen using a square 
template (1 cm
2
) and demarcated with permanent ink.  The creams were applied for three days 
on two of three sites, while a site was  left untreated (control). On the third day the three sites 
were irradiated with the MED determined for each subject, On the fourth day the induced 
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erythema was monitored by means of a reflectance visible spectrophotometer, providing 
measures of the three coordinates of CIELAB:  L*, a* and b*. 
 6.2.9 Preparation of melanin from DHICA and MeDHICA 
Autooxidatio melanins were obtained by autoxidation of 10 mM solutions of DHICA or 
MeDHICA in 0.1 M phosphate buffer at pH 8.5. The oxidation mixtures were allowed to 
stand at room temperature under vigorous stirring. Oxidation was halted at complete 
monomer consumption as determined by HPLC analysis and then acidified to pH 2. The 
melanin precipitate was collected by centrifugation (7000 rpm, 10 min, 4 °C) and was washed 
three times with 15 mL of 0.01M hydrocloridric acid (95 % and 65 % yield).  
In another set of experiments, 3 molar equivalents of potassium ferricyanide were added to 10 
mM solutions of DHICA or MeDHICA in 0.1 M phosphate buffer at pH 7.0. The oxidation 
mixture was allowed to stand at room temperature under vigorous stirring for 10 min and then 
acified to pH 2. The melanin precipitates were collected by centrifugation (7000 rpm, 1020 
min, 4 °C) and washed three times with with 15 mL of 00.1M hydrocloridric acid (86% and 
93% yield). 
 6.2.10 Test of the solubility of melanin from DHICA and MeDHICA 
Melanin prepared by autooxidation from DHICA or MeDHICA (0.3 mg/mL) were 
suspended/dissolved in methanol or DMSO. The materials were stirred in the appropriate 
solvent for 15 min and UV-vis spectra of supernatants were registered after centrifugation 
(5000 rpm, 10 min, and 4 °C) and appropriate dilution. 
 6.2.10  2,2-Diphenyl-1-picrylhydrazy (DPPH) assay 
The assay was performed as previously described.
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 Briefly, to a 200 μM DPPH solution in 
methanol, a proper amount of a methanolic suspension of each melanin homogenized with a 
glass/glass potter was added and rapidly mixed. The reaction was followed by 
spectrophotometric analysis measuring the absorbance at 515 nm after 10 min. Values are 
expressed as the EC50 i.e. the dose of the material at which a 50% DPPH reduction is 
observed, 
 6.2.11 Ferric reducing/antioxidant power (FRAP) assay 
The assay was performed as described.
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 To a solution of FRAP reagent, a proper amount of 
a methanolic suspension of each melanin homogenized with a glass/glass potter was added 
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and rapidly mixed.  After 10 minutes, the absorbance at 593 nm was measured. Trolox was 
used as the standard and results were expressed as Trolox equivalents. The FRAP reagent was 
prepared freshly by mixing 0.3 M acetate buffer (pH 3.6), 10 mM 2,4,6-tris(2-pyridyl)-s-
triazine in 40 mM HCl, and 20 mM ferric chloride in water, in the ratio 10 : 1 : 1, in that 
order. 
6.3 Hyperpigmentation and strategies of control of melanin pigmentation 
 6.3.1 Materials 
2-iodobenzoic acid, oxone, lipoic acid (LA), sodium borohydride, sodium dithionite, 3,4-
Dihydroxy-L-phenylalanine (L-DOPA), mushroom tyrosinase (EC 1.14.18.1), kojic acid, were 
purchased from Sigma-Aldrich. Coumaric acid (CA) was purchased by Fluka. All solvents 
were HPLC grade. Bidistilled deionized water was used throughout the study. 
 6.3.2 Methods 
UV spectra were recorded on a Beckman DU 640 spectrophotometer. 
NMR spectra were recorded at 400 MHz on a Bruker instrument. 
HPLC analyses were performed on a Agilent 1100 binary pump instrument equipped UV-
visible detector  using an octadecylsilane-coated column, 250 mm x 4.6 mm, 5 m particle 
size (Phenomenex Sphereclone ODS) at 0.7 mL/min, using the following gradient: 0.1% 
formic acid (eluant a)/ methanol (eluant b): 40% b, 0-10 min;  from 40 to 80% b, 47.5-52-5 
min; from 80 to 40% b, 52.5-57.5 min. Detection wavelength was set at 280 nm. 
LC-MS analysis was performed on an HPLC 1100 VL series instrument with an electrospray 
ionization source in positive ion mode (ESI+). An Agilent Eclipse XDB-C18 (150  4.60 mm, 
5µm) was used, with the same eluant used for the HPLC analysis at a flow rate of 0.4 
mL/min. Mass spectra were registered with the nebulizer pressure 50 psi; drying gas flow  10 
L/min,  at 350 °C;  cap voltage set at 4000 V. 
6.3.3 Synthesis of 2-iodoxybenzoic acid (IBX) 
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5.0 g of 2-iodobenzoic  acid were added to 37.2 g of Oxone previously dissolved in 200 mL 
of bidistilled water and the mixture was taken under stirring at 70 °C. After 1 h the solution 
was cooled at 4 °C for 30 min, filtered and washed with cold water (6  300 mL) and acetone 
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(2  30 mL). The white solid was left to dry at room temperature for 16 h and weighted 
(3,085g, 55% yield).   
6.3.4 Preparation of DHLA (6,8-dimercaptoottanoic acid) 
Preparation of DHLA (6,8-dimercaptoottanoic acid) To 1.0 g of lipoic acid, previously 
dissolved in 20.0 mL of an aqueous solution of NaHCO3 (0.25 M), were added 740.0 mg of 
NaBH4  (in two portions) and the mixture was taken under stirring at 0 °C. After 2 h the 
reaction mixture was acidified until pH 1 with HCl 6 M and extracted with toluene (5  20 
mL). The residue was analyzed by 
1
H NMR to give DHLA in a pure form (902mg, 89 % 
yield). 
 6.3.5 Synthesis of 2-S-lipoylcaffeic acid 
A solution of p-coumaric acid (215. mg, 1.3 mmol) in methanol (18 mL) was treated with 
IBX (561 mg, 2 mmol) under vigorous stirring at room temperature. After 7 min a solution of 
DHLA (1.119 mg, 5.3 mmol) in methanol (18 mL) was added drop by drop. After additional 
15 min the reaction mixture was dilute with water and acidified with HCl 6 M to pH 1. Then 
the mixture was extracted with hexane/toluene 8:2 (10  200 mL), chloroform (7  200 mL) 
and ethyl acetate (3×100 mL). The combined chloroform layers were dried over sodium 
sulfate and taken to dryness to afford pure lipoyl-CA (101 mg, 20% yield) as an oily solid.  
ESI+/MS: m/z 387 ([M+H]+), 409 ([M+Na]+);  
UV: max (CH3OH) 252, 320 nm; 
 
1
H NMR (CD3OD)  (ppm): 1.38 (m, 1H), 1.54 (m, 1H), 1.54 (m, 2H), 1.42(m, 1H), 1.62 (m, 
1H), 1.78 (m, 1H),e 1.81(m, 1H), 2.26 (m, 2H), 2.88 (m,1H), 2.90 (m, 1H), 2.96 (m, 1H), 6.29 
(d, J=16 Hz, 1H), 6.86 (d, J=8.4 Hz, 1H), 7.22 (d, 1H), 8.40 (d, J= 16 Hz, 1H).  
13
C NMR (CD3OD)  (ppm): 25.4 (CH2), 27.3 (CH2), 34.1 (CH2), 34.1 (CH2), 39.4 (CH2), 
39.4 (CH2), 40.2 (CH), 117.2 (CH), 118.1 (CH), 119.9 (CH), 121.7 (C), 130.7 (C), 144.2 
(CH), 147.7 (C), 147.8 (C), 168.2 (C), 174.8 (C). 
 6.3.6 Assay of mushroom tyrosinase activity 
100 μL  of a methanolic solution of 2-S-lipoylcaffeic acid (final concentration 0.001-1mM) 
was incubated in 2 mL of 50 mM phosphate buffer (pH 6.8) at room temperature in the 
presence of mushroom tyrosinase (10 U/mL). After 10 min 20 μL of a 100 mM solution of L-
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DOPA in 0.6 M HCl (final concentration 1 mM) were added and the course of the reaction 
was followed by spectrophotometer measuring the absorbance at 475 nm every two minutes 
for ten minutes. 
In separate experiments the assay was run as above incubating 2-S-lipoylcaffeic acid (final 
concentration 250 μM) in the presence and in the absence of 20 μL of a 100 mM solution of 
L-DOPA in 0.6 M HCl (final concentration 1 mM) and the course of the oxidation was 
followed by HPLC. 
6.3.7 Study of the mechanism of inhibition of mushroom tyrosinase activity 
The assay was run as above, using different concentration of L-DOPA (2, 1, 0.5, 0.25 and 
0.125 mM) and 2-S-lipoylcaffeic acid. (0, 2, 3 and 5 μM). Data were elaborated to build the 
Lineweaver-Burk plot. 
6.3.8 Assay for monophenolasic mushroom tyrosinase activity 
100 μL  of a methanolic solution of 2-S-lipoylcaffeic acid (final concentration 0.001-1mM) 
was incubated in 2 mL of 50 mM phosphate buffer (pH 6.8) at room temperature in the 
presence of mushroom tyrosinase (10 U/mL). After 10 min 20 μL of a 100 mM solution of L-
tyrosine in 0.6 M HCl (final concentration 1 mM) were added and the course of the reaction 
was followed by spectrophotometer measuring the absorbance at 475 nm every 20 s for 15 
min. 
6.3.9 Effect of the preincubation on the inhibitory activity 
10 μL of a methanolic solution of 2-S-lipoylcaffeic acid (final concentration 3.7 μM) were 
added to 2  mL of 50 mM phosphate buffer (pH 6.8) containing mushroom tyrosinase (20 
U/mL) and was followed by the immediate addition of 20 μL of a 100 mM solution of L-
tyrosine in 0.6 M HCl (final concentration 1 mM). The course of the reaction was followed by 
spectrophotometer measuring the absorbance at 475 nm every two minutes for ten minutes. 
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